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The influenza virus infects about 5 to 15 % of the world population every year, caus-
ing a disease that is well-known as ‘the flu’. These infections result in an estimated three
to five million cases of severe illness, causing on average 250 to 500 thousand mortali-
ties annually.24 Influenza has a significant economic impact in terms of work and school
absence, loss of productivity, the cost of research on new treatments and the develop-
ment and application of seasonal vaccinations.19 Yearly updates of broadly neutralizing
influenza vaccines can help protect the most vulnerable people from the virus, but these
drugs do not offer complete protection against infection.16 Moreover, spontaneous genetic
mutations can produce new virus strains that are immune to current vaccines, which can
potentially cause a world-wide pandemic.10 The 1918 ‘Spanish flu’ has been the largest
documented influenza pandemic in history, infecting an estimated 500 million people and
killing at least 50 million of those across the world.20 These observations illustrate the
significance of ongoing fundamental research into the mechanism of influenza virus in-
fection. The severe threat of a new pandemic remains, unless a common mechanism in
the replication cycle of influenza is found that can be suppressed for all influenza virus
strains.11
Figure 1.1: Schematic view of an influenza virus particle, with its main constituents: Hemagglutinin
(blue); Neuraminidase (red); the M2 ion channel (purple); the viral RNP, which contains the RNA
(green); the lipid bilayer (light brown) and the M1 protein coat (maroon). 2
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Figure 1.2: Schematic representation of the influenza replication cycle. Reproduced with permission of
the ©ERS 2015. 9
1.1 Influenza viral entry and replication
Virus particles can be regarded as tiny devices that take over a host cell and use it to gener-
ate their offspring, thereby ensuring the survival of their own species.17 The basic design
of such a device is illustrated for the influenza virus in Figure 1.1. Influenza virus particles
can be either spherical or filamentous, and have an average size of 80 to 100 nm. At the
core of the particle lies the blueprint of the design – the viral genome (ribonucleoprotein;
RNP) that encodes the sequences of the viral proteins. The purpose of the particle is to
deliver the viral genome to the nucleus of a target cell. The genome is protected from the
environment by a matrix protein M1 layer, which, in turn, is surrounded by an envelop-
ing lipid bilayer. The three proteins that are embedded within this membrane are the M2
ion channel and the glycoproteins neuraminidase (NA) and hemagglutinin (HA).13,14 In-
fluenza virus strains are named according to the antigenic character of their HA and NA
proteins, currently ranging from H1 to H18 and N1 to N11, so a strain with HA subtype 3
and NA subtype 2 is called H3N2. All virus proteins have a role in the replication cycle of
the virus, as discussed next.
The invasion strategy of the influenza virus is illustrated in Figure 1.2. Upon enter-
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ing the respiratory tract of the host, receptor binding domains on the globular head of
HA adhere the particle to sialic-acid moieties on the surface of epithelial cells.22 The
particle is then internalized into an endosome by either clathrin-mediated endocytosis
or macropinocytosis.5 The host cell traffics the endosome towards its nucleus, thereby
gradually increasing the acidity within this compartment. Between the maturing and late
endosome, a pH below 6 triggers HA to carry out its next task: membrane fusion.12 HA
merges the viral and endosomal membrane, thereby exposing the viral genome to the cell
cytoplasm.18 Concurrent acidification of the particle interior by the M2 ion channel causes
uncoating of the genome through dissociation of the M1 matrix protein.15 The viral RNP
enters the host cell nucleus through the nuclear pore complex and starts the synthesis of
viral proteins and ribonucleic acids (RNA). This ultimately leads to new virus particles
budding from the cell membrane and their NA-mediated release.7
1.2 Entry inhibition
A number of steps in the replication cycle of the influenza virus can be used as a target
for antiviral drugs. Entry inhibition strategies interfere with, for example, binding of HA
to cellular receptors, cellular processes that mediate endocytosis, M2-mediated uncoating,
HA-mediated membrane fusion or the import of the viral genome into the cell nucleus.6
The pivotal role of HA in both binding and fusion, combined with its exposure to extra-
cellular compounds, makes it a particularly popular target for neutralizing antibodies or
small-molecule inhibitors.21 However, mutations in the amino acid sequence of the protein
can happen during replication, in a process called antigenic drift. These mutations cause
small changes in the appearance of an HA subtype that make it less recognizable by an-
tibodies or inhibitors and therefore more successful in infection.1 Antigenic drift happens
within the subtype and is not be confused with antigenic shift, a process in which two or
more different strains of a virus infect the same host and combine into a new one, e.g.,
H3N2 and H5N1 could form H5N2.25 Because the human immune system would have
difficulty recognizing such a new subtype, it may result in a highly dangerous, pandemic
virus strain. An ideal antiviral drug should therefore universally apply to all virus strains,
inhibiting a mechanism that is crucial for their replication, such as membrane fusion.11
1.3 Hemagglutinin-mediated membrane fusion
During cell entry of influenza viruses, fusion of the viral and endosomal membranes is
mediated by HA. The fusion of two lipid bilayers progresses over a number of intermediate
states that are separated by appreciable energy barriers. Membrane fusion would therefore
not occur on a biologically relevant timescale without the input of energy from a fusion
catalyst, such as HA.4 HA is a trimeric glycoprotein consisting of 1647 residues that can
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be divided into two parts: HA1 and HA2. HA1 is mostly globular and is mainly responsible
for binding. HA2 is the fusion-active subunit and its central triple-stranded coiled coil
forms the core of the protein. HA1 covers HA2, maintaining the protein in a metastable
conformation.
A proposed pathway for HA-mediated membrane fusion8 is depicted in Figure 1.3.
This sequence of events has been deduced from comparison of the known structures of HA
at neutral pH (the prefusion state, Figure 1.3a) and at low pH (postfusion, Figure 1.3d),
showing a large conformational change.3,23 HA1 dissociates upon acidification (Figure
1.3a-b), enabling HA2 to get from its metastable prefusion state into an extended inter-
mediate via a coil-to-helix transition, inserting the amphipathic fusion peptide (red star in
the figure) into the target membrane (Figure 1.3b-c). A helix-to-coil transition causes the
intermediate to collapse, bringing the two membranes together for fusion (Figure 1.3c-e).
This working hypothesis for HA-mediated fusion leaves a number of open questions:
What are the exact intermediates and what is the kinetics of the transformations between
them? Which of the steps are pH-dependent? And which of the residues in HA are essential
Figure 1.3: Proposed sequence of conformational changes in influenza HA that drive fusion, based on
its (a) prefusion and (b) postfusion structure. 3,23 HA is shown in cartoon representation, with each
monomer in a different colour (red, green and blue). The position of one fusion peptide is marked with a
red star. The gray bar represents the (top) target and (bottom) viral membrane, in which HA is anchored
by a transmembrane domain (coloured bars). From (a) to (b), the pH drops and HA1 dissociates. From
(b) to (c), the fusion peptides are released, a subsequent coil-to-helix transition extends HA2 and the
fusion peptides insert into the target membrane. The extended intermediate collapses from (c) to (d),
with a helix-to-coil transition and unfolding of the globular domain at the bottom of HA2. In (d) this
globular domain has zippered up along the central coiled coil, carrying the transmembrane domain
towards the fusion peptide. A tight interaction between the regions near the fusion peptide and the
transmembrane domain (e) subsequently drives formation of the fusion pore. Adapted by permission
from Macmillan Publishers Ltd: Nature Structural & Molecular Biology, 8 copyright (2008).
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for the process? Are these conserved through different influenza subtypes? Also, how much
energy can HA deliver in order to fuse the membranes? Consequently, how many HAs are
needed to successfully fuse the membranes?
1.4 Molecular dynamics simulations
We set out to answer the research questions on HA-mediated membrane fusion using
molecular dynamics simulations. These simulations give a trajectory of the atomic posi-
tions of the system (solute and solvent) over time, from which the desired properties can
be extracted by further analysis. In order to generate such a trajectory, the displacement
of a particle is calculated over a finite time step, based on the instantaneous forces be-
tween the particles at the beginning of that step. These forces are given by a predefined
force field, parametrized against observables from experiments or quantum-mechanical
simulations.
There are three major challenges in modeling HA and simulating its mechanistic be-
haviour using this method:
• System size
The HA trimer consists of more than 15 000 atoms, between which the forces need
to be calculated at every time step.
• Large conformational change
Dynamical simulation of the dramatic conformational change in HA requires long
simulation times, so a large number of time steps, and/or enhanced sampling meth-
ods.
• pH-dependence
Methods for dynamic protonation of ionizable residues during molecular dynamics
simulations increase the computational demands substantially.
As not all of these challenges can be tackled at the same time, our approach is to reduce
system size and complexity by making informed assumptions and approximations. For
example, only the parts of the protein that are relevant for the research question at hand
are simulated.
1.5 Thesis outline
This thesis is devoted to improving our understanding of hemagglutinin-mediated mem-
brane fusion, with a potential view on the development of a universal anti-influenza drug.
After the brief introduction on HA-mediated membrane fusion given already here, Chap-
ter 2 discusses the current literature on this subject more thoroughly. This includes a de-
scription of the intermediate membrane configurations involved in the membrane fusion
References 7
process and a quantification of the energy barriers between them. The pathway of the HA
rearrangements and their role in mediating membrane fusion are discussed next. The de-
scription of the stochastic model that follows, explaining how multiple HAs can mediate
fusion together, completes the current biophysical perspective on HA-mediated membrane
fusion.
In Chapter 3, two molecular dynamics explicit solvent models are being compared, in
the search for an accurate representation of peptide and protein conformations. The com-
parison focuses on the correct balance between folded and unfolded conformations, which
is important in, for example, the coil-to-helix and helix-to-coil transition in HA. Three dif-
ferent peptides are simulated using an enhanced sampling technique, and the results are
compared to their folding characteristics in experiments. The combination of force field
and water model thus found is applied in all explicit solvent simulations reported on later
in this thesis.
Chapter 4 presents the simulation results of only a small part of HA: the globular
bottom of HA2. The stability of this domain is hypothesized to determine HA productivity,
by regulating the amount of time that is available for the fusion peptides to insert into
the target membrane. Steered molecular dynamics simulations in explicit solvent are used
to study the unfolding behaviour of this domain and to determine which residues are
critical for its stability. Preliminary results from single-particle fusion kinetics experiments
are consistent with our expectation that the found residues influence HA-mediated fusion
efficiency. Additionally, the results indicate a possible pH-dependence in globular bottom
stability that might trigger this intermediate step, and even include a number of conserved
residues that seem to be crucial for productive membrane fusion.
In the final chapter, the amount of energy that one HA can deliver to the fusion process
is calculated using the confinement free energy method. Because only HA2 is actively
involved in the fusion process, HA1 does not need to be simulated. Still, the calculation of
this single quantity requires a huge computational effort and the use of enhanced sampling
techniques. Furthermore, the used method currently does not seem feasible in explicit
water, so an implicit water model is used. The amount of energy that is found for one HA
is similar to what has been found experimentally for other fusion proteins, and supports a
model in which a local cluster of three HAs is needed to mediate fusion.
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Hemagglutinin-mediated membrane fusion: A biophysical
perspective
Abstract
Hemagglutinin (HA) is a viral membrane protein responsible for the initial steps of the
entry of influenza virus into the host cell. It mediates binding of the virus particle to the
host cell membrane and catalyzes fusion of the viral membrane with that of the host. HA
is therefore a major target in the development of antiviral strategies. The fusion of two
membranes is thermodynamically favourable, but involves high activation barriers and
proceeds through several intermediate states. Here we provide a biophysical description
of the membrane fusion process, relating its kinetic and thermodynamic properties to the
large conformational changes taking place in HA, and placing these in the context of mul-
tiple HA proteins working together to mediate fusion. Furthermore, we highlight the role
of novel single-particle experiments and computational approaches in understanding the
fusion process, and their complementarity with other biophysical approaches.
Boonstra S, Blijleven JS, Roos WH, Onck PR, van der Giessen E, van Oijen AM. Hemagglutinin-mediated mem-
brane fusion: A biophysical perspective. Annu. Rev. Biophys. Submitted.
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2.1 Introduction
Many biological processes rely on mixing the contents of two separate compartments.
This mixing step requires fusion of the lipid membranes enveloping the compartments,
a thermodynamically favourable transition but with an appreciable kinetic barrier. Fusion
proteins act as catalysts to overcome this barrier so that fusion takes place within biological
timescales.98 A classical example is the SNARE complex: a group of proteins that not
only mediate fusion of vesicles in synaptic transmission between neurons,119 but are also
involved in cargo transport between the Golgi apparatus and the endoplasmatic reticulum,
and catalyse fusion between the late endosome and the lysosome.61 Another example that
has been the subject of intense study for decades and that has great significance to human
health is the group of fusion proteins that mediate cell entry of membrane-enveloped
viruses.50,73 In this review, we will focus on the influenza hemagglutinin fusion protein
as a canonical example of a viral fusion protein, and take a biophysical perspective in
describing its mechanism of action.
The replication cycle of viruses relies on invading target cells and using them for the
production of new virions. The viral genome, to be delivered to the nucleus of the target
cell, is carried inside a protein capsid. Enveloped viruses are characterized by a lipid bilayer
that envelops the protein capsid. Embedded in this membrane are the viral fusion proteins,
which can be activated by binding to a specific receptor on the surface of the target cell
or by a change in pH in the acidifying endosome.143 Upon activation, the fusion proteins
establish a physical connection with the target cell by insertion of hydrophobic segments
into the target membrane. Extensive refolding of the fusion protein brings the membranes
in close proximity for fusion, resulting in the formation of a pore through which the viral
genome is released into the cytosol of the target cell.20
Three structural classes of viral fusion proteins have been identified.49 Class I fusion
proteins (found in e.g. HIV-1 and influenza) consist of homotrimers that are primed by
enzymatic cleavage, creating two distinct subunits. One is responsible for receptor binding
and the other for fusion, with the fusion-active subunit containing primarily alpha-helical
motifs. Class II proteins (in alpha- and flaviviruses, and others) exist as hetero- or ho-
modimers on the viral surface but trimerize upon activation. They are primed by cleavage
of a partner protein and have a large amount of beta sheets in their structure. Class III
(from e.g. rhabdo- and herpesvirus) represents a mixture of the other two.50 The focus of
this review is on the class I fusion protein hemagglutinin (HA) from influenza.129 Since
the elucidation of its structure in 1981,145 extensive research into the relation between
its complex series of conformational changes and its ability to fuse two lipid bilayers has
made HA the archetypal membrane-fusion protein, serving as an example for the operating
mechanisms of other fusion proteins.50,128
A vast amount of knowledge has already been acquired on HA, from structural in-
formation to kinetic data, and various experimental methods have been developed to re-
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constitute HA-mediated membrane fusion with careful control over binding and fusion.
These studies and methods have made HA-catalyzed fusion into an ideal model system
to understand the biophysical principles underlying protein-mediated membrane fusion.
Additionally, HA is one of the primary targets for antiviral drugs against influenza.137
However, the ability of the virus to extensively mutate without losing function has thus
far prevented the development of long-lasting vaccines. An improved insight into the fu-
sion process as well as the intermediate protein and lipid conformations involved may
help to identify conserved aspects of HA-mediated membrane fusion. Targeting conserved
residues that are crucial for this mechanism provide a strategy for the development of a
universal, rationally designed antiviral drug.139 Lastly, understanding the viral entry path-
way can help in employing viral fusion mechanisms for more efficient delivery of targeted
therapeutic agents. Such an approach is a potential route to better drug efficacy, since the
escape of the agent from the endosome currently is a major hurdle for the delivery of such
therapeutics.138
This review combines recent structural and physical insights from experimental and
computational studies to provide an up-to-date biophysical perspective on HA-mediated
membrane fusion. We describe the pathways and energetics of the process, starting with
the membrane rearrangements, followed by the conformational changes in HA. We then
continue by discussing the role of multiple copies of HA in membrane fusion and conclude
with a discussion of future research directions in this field.
2.2 Membrane fusion
Biological membranes consist of two amphipathic lipid monolayers that aggregate their
lipid tails to form a hydrophobic layer. The delineating hydrophilic lipid head groups pro-
vide solvability to this planar aggregate. Fusing two separate membranes into one gen-
erally involves a hemifusion intermediate in which only the proximal monolayers have
merged.16 Pore formation, through subsequent union of the distal monolayers, completes
the fusion process. Zooming in on the process, several distinct intermediate states can be
distinguished that have modest free energy differences, but are separated by relatively
high energy barriers. After introduction of the fusion pathway, we first give a description
of the methods for characterization of fusion intermediates and barriers with a focus on
just the membranes, followed by a discussion of the physical origin behind these barriers
and current barrier-height estimates.
2.2.1 Pathway
The canonical pathway of membrane fusion is illustrated in Figure 2.1a. Upon dehydration
and bringing the two bilayers into close proximity, the nearest monolayers fuse to form a
stalk. Radial expansion of the stalk creates a hemifusion diaphragm (HD) in which only the
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Figure 2.1: (a) Schematic representation of intermediates in the canonical membrane-fusion pathway
and (b) the height of the energy barriers between them. The barriers for the single-step transitions
directly to hemifusion and from there to pore formation are shown in blue. Several studies split the
free-energy landscape into additional intermediate steps (indicated by the red, purple and green ar-
rows in (a)) and associated barriers (indicated by correspondingly coloured curves in (b)), e.g. stalk
formation from an already dehydrated state (red), the formation of a hemifusion diaphragm from the
stalk (purple) and pore formation in the hemifusion diaphragm (green). Each of the barriers in (b)
is drawn as a range between the maximum and minimum free energy barriers reported in the litera-
ture. 1,66,69,90,101,121,131 The barrier estimates from these studies were selected based on parameters most
relevant to influenza fusion (see text). The barrier shape is schematic. Solid barrier lines are only drawn
as guides to the eye, mid-way through each of the ranges of previously reported energies. To aid com-
parison of the barrier heights, the absolute free energies of all intermediate states are aligned at 0 kBT.
The arrows on the horizontal axis indicate contributions from protein-mediated events that can possibly
lower the corresponding barrier, as discussed in Section 2.3: zippering, fusion peptide (FP) and trans-
membrane domain (TMD). An overview of barrier data, including those displayed, can be found in Table
2.A.1 in Appendix 2.A.
proximal leaflets have merged and the distal leaflets touch. Full fusion can proceed through
pore formation within the HD, or more directly from a minimally expanded stalk.17,106
Alternative routes ensuing stalk formation, which involve lateral stalk expansion or a stalk-
pore complex,36,96 will only be treated briefly here.
2.2.2 Methods
Direct visualization of short-lived intermediates of membrane fusion at the relevant
nanoscopic length scales demands experimental assays with very high temporal and
spatial resolution. X-ray diffraction experiments have allowed for the visualization of stalk
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geometries and enabled the determination of the dehydration barrier through analysis of
the inter-bilayer separation as a function of osmotic pressure.122 Hemifusion diaphragms
have recently been observed using confocal microscopy on giant unilamellar vesicles105
and in live cells.150 HDs18 and extended areas of closely apposed membranes46 have
been imaged by cryo-electron tomography (cryo-ET). The kinetics of hemifusion and pore
formation have been observed using optical tweezers108 and fluorescence microscopy,90
methods that can be combined with single-particle tracking110 as discussed later in this
review.
These experimental assays are supplemented by modeling approaches to provide ad-
ditional information on the molecular and energetic details of the fusion intermediates.
Computational models can be divided into continuum elasticity theories10 and particle-
based numerical simulations.36 Starting from the Helfrich model of membrane bending,51
continuum elastic models have been formulated to incorporate lipid tilting,81 lipid splay-
ing,79 membrane stretching,121 membrane dehydration and saddle-splay deformation.78
In all these methods, energy minimization provides the optimal shape and free energy
of fusion intermediates. Particle-based molecular dynamics (MD) simulations are based
on the instantaneous interactions between individual atoms31 or groups of atoms.57 An
advantage of MD simulations is that the system can explore conformational space and re-
action pathways in an unbiased and unguided manner, potentially resulting in alternative
fusion pathways. A disadvantage is that many transition trajectories are needed to get an
accurate estimate of the free energy,64 so enhanced sampling methods often have to be
used.102,130
2.2.3 Barriers
Transitions between intermediate states of membrane fusion involve appreciable energetic
barriers arising from unfavourable lipid interactions, such as dehydration of polar lipid
head groups, generation of membrane curvature, and transient exposure of hydrophobic
lipid tails to the aqueous environment. The height of these energy barriers depends on the
membrane composition, tension and initial curvature,17,75,76,96 as summarized in Figure
2.1b. Because of the large number of variables involved, we only consider the canonical
fusion pathway, using values reported for lipid compositions that are close to that of the in-
fluenza membrane envelope41,115 (approximately POPS:DOPE:cholesterol:sphingomyelin
1.5:1.5:5:2) and the epithelial cell membrane123 (approximately POPC:POPE:cholesterol
2:1:1). A more comprehensive overview of barrier estimates can be found in Table 2.A.1
in Appendix 2.A.
The first barrier in membrane fusion, the dehydration barrier, is formed by repulsive
hydration forces that have to be overcome to bring the bilayers into sufficiently close con-
tact (< 1 nm).121 The formation of dimples on the membranes could lower this barrier
by decreasing the area of close contact.81 As can be seen from Figure 2.1b, a dehydration
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barrier in the range of 30 to 90 kBT has been estimated for influenza fusion,
1,69 depending
on the specific geometry and lipid composition. This estimate includes the entire transition
from unfused membranes to a stalk.
Once in a dehydrated state, stalk formation is initiated by the protrusion of a splayed
lipid tail, establishing a lipid bridge with the opposing membrane.97,131 Such protrusions
are most favourable at an inter bilayer distance of 0.9 nm and are more probable with in-
creasing membrane curvature.134 Hence, the height of the barrier to stalk formation is de-
pendent on the initial membrane separation and curvature, a fact that is often overlooked
when citing quantities for this free energy barrier.1 In dehydrated conditions, a remain-
ing 15 to 30 kBT barrier for stalk formation is estimated (red barrier in Figure 2.1b) from
MD simulations.66,101,131 This value corresponds well with estimates from experiments
in the presence of high-molecular weight polyethylene glycol or fusion proteins, such as
SNARE.90,108 Such protein mediation in membrane dehydration will be discussed in more
detail in the next section.
A stalk state can lead to a pore in a single step, or through stalk expansion and
subsequent formation and expansion of a hemifusion diaphragm. Estimates of the stalk-
expansion barrier with membranes of physiologically relevant composition range from
14 to 33 kBT (purple barrier in Figure 2.1b).
66,90,116,121 This barrier arises from the op-
posing directions of intrinsic curvature between different lipids in and outside the HD,
specifically near the rim of the HD.121 During HD expansion, tension can build up along
the rim until a pore forms.77 The energy required for expansion of such a rim-proximal
pore increases with HD diameter,118 suggesting a limited window of opportunity for pore
formation during HD expansion, as corroborated by observation of large, fusion-arrested
HDs using cryo-ET.18 A pore formation barrier of 14 to 35 kBT has been predicted within
an HD diameter smaller than 10 nm (green barrier in Figure 2.1b),66,121 which agrees well
with estimates from experiments.90,108
The single-step formation of a pore from a minimally expanding stalk faces an esti-
mated 90 to 120 kBT (second blue barrier in Figure 2.1b).
69,121 The pathway through an
expanding hemifusion diaphragm has lower barriers, but protein mediation and the spe-
cific conditions of membrane curvature and tension can favour the direct transition from
a stalk to a pore.66,108
After its formation, the pore needs to expand in order for the virus to release its bulky
contents into the host. Pore expansion has been reported to be energetically the most de-
manding step,16,21 with membrane tension as the primary contributing factor.75 Indeed,
pore expansion in cell fusion was found to be highly dependent on the density of HA fusion
proteins,88 and similarly on SNARE density.147 Live-cell imaging has reported fusion-pore
opening and closing (flickering) prior to full fusion, implicating the presence of cell-specific
fission mechanisms that compete with fusion pore opening.150 These observations empha-
size the importance of the biological context involving membrane, protein and environ-
mental parameters. In order to distil the biophysical effects of each variable, dedicated
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experiments are crucial. Before we review an example of such an experiment, we first
discuss the HA fusion protein in more detail.
2.3 Hemagglutinin conformational changes
Influenza membrane fusion is mediated by the HA fusion protein. The prefusion (Figure
2.2a)145 and postfusion structure of HA (Figure 2.2b)8,15 revealed that extensive confor-
mational changes are involved in its fusogenic activity. Biochemical and computational
studies have provided further information on the triggering mechanism and possible in-
termediate states, which has led to several hypothesized pathways of the conformational
changes. As we will discuss here, these structural states and transitions can be related to
the intermediate states and energy barriers involved in membrane fusion.
2.3.1 Structure and triggering
The HA glycoprotein is a 13.5-nm-long trimer that is synthesized as the inactive precur-
sor HA0. It enters a metastable conformation after enzymatic cleavage, comprising two
disulfide-bonded chains per subunit, HA1 and HA2 (Figure 2.2a).145 HA1 (328 residues,
orange in the figure) forms the globular head of the protein and mediates attachment to
sialic-acid receptors on the target cell by its receptor-binding domain. HA1 further plays
a role in maintaining the protein in its metastable state at neutral pH, by covering the
fusion-active subunit, HA2 (221 residues). A triple-stranded alpha-helical coiled coil in
HA2 forms the core of the protein, sitting on top of a small globular domain (black in Fig-
ure 2.2) that contains the disulfide bond with HA1. The 23 residues near the N-terminal of
HA2 make up an amphipathic fusion peptide (red) that is tucked away in a hydrophobic
pocket between the central alpha helices at neutral pH. The transmembrane domain at the
C-terminal of HA2 anchors the protein in the viral membrane.
The drop in pH to a value between 5 and 6 in the maturing-to-late endosome82
activates a series of conformational rearrangements in the protein. Computer simula-
tions have indicated that protonation of residues around the fusion peptide, in particu-
lar residue Asp112,93 is the major trigger to release the fusion peptide from its pocket
(Figure 2.2b).26,151 Hydrogen-deuterium exchange with mass spectrometry (HDX-MS) ex-
periments have further shown that reversible release of the fusion peptide35 precedes the
dissociation of the interface between neighbouring HA1 subunits within the trimer,39 the
latter being a necessary step for function.44,71 Protonation of residues at this HA1-HA1
interface26 and increased electrostatic repulsion between HA1 subunits drive their disso-
ciation,28,54,151 while they remain bound to the receptors (Figure 2.2b).124
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2.3.2 Pathways of the conformational change
After fusion-peptide release and HA1 dissociation, HA2 undergoes extensive conforma-
tional changes before entering the postfusion state.8,15 Depending on the rates of the
conformational changes of individual segments, two pathways have been proposed that
successfully bring the two membranes together for fusion.
In the first productive pathway (Figure 2.2 Row 1),17 the unstructured B-loop (navy
blue) folds into a coiled coil (with rate kextension, proposed to be independent of pH
53). This
coiled-coil structure extends the existing coiled coil, bringing along the fusion peptide for
insertion into the target membrane (Figure 2.2-c1).133 This conformational change forms
the elusive extended intermediate, a state that thus far has escaped structural character-
isation. Only recently, direct indications of the existence of the extended structure have
been observed in a cryo-ET study.9 Intriguingly, the strong coiled-coil propensity of the
B-loop region is suppressed during the folding of HA in the endoplasmic reticulum and
extension only becomes possible after priming by enzymatic cleavage.14 This highlights
the metastability of the prefusion structure and suggests a ‘spring-loaded’ mechanism.11
The second structural change involves partial unfolding of the central helix from the
point where the fusion peptides initially were tucked away. Here, the hinge region (purple)
at the bottom of the central helix folds back towards the remaining coiled coil, at a rate that
is lower than the initial HA extension (kfoldback < kextension) (Figure 2.2-d1). The tendency
towards this fold-back transition is another example of a built-in structural metastabil-
ity in the prefusion structure, owing to a shift in the coiled-coil heptad repeat.126 From
the extended intermediate, with both membranes connected through the protein structure
(Figure 2.2-c1), the foldback seems possible only once the globular domain (black) has
sufficiently unfolded. The unfolded globular domain subsequently packs as a ‘leash’ into
the grooves of the coiled coil, zippering up along a ladder of distinct hydrophobic patches,
culminating in stabilizing N-cap interactions15,112 and fusion peptide and transmembrane
domain association.12,83 Indirect evidence for this pathway comes mainly from the in-
hibition of fusion by peptides that bind to the extended intermediate of the HIV fusion
protein,144 an approach that also works with peptides targeting HA, albeit at much higher
peptide concentrations.87
Two other pathways are possible from the moment of activation, depending on the rel-
ative rates kextension and kfoldback. The second productive pathway was predicted by MD sim-
ulations of HA2 using a structure-based bias,92 later supplemented by unbiased all-atom
MD (Figure 2.2 Row 2).93 For values of kextension that are sufficiently smaller than kfoldback,
rapid foldback before complete unfolding of the globular domain leads to a ‘symmetry-
broken intermediate’ (Figure 2.2-c1). Diffusion-limited insertion of fusion peptides in both
the target and viral membrane would allow for the bundling of energy from both coiled-
coil formation and zippering. No experimental evidence has confirmed the existence of
this pathway yet.
In the non-productive pathway (Figure 2.2 Row 3), foldback happens almost simul-
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Figure 2.2: Schematic representation of the conformational changes in HA and the corresponding mem-
brane rearrangements. Only two subunits of the trimer are shown and HA1 is omitted in (c)-(f) for
clarity. The protein structures displayed below panels (a) and (b) show the transition from the prefu-
sion 125 to the postfusion state, 15 with one monomer highlighted in each of the states. HA binds to cell
receptors (a, brown) and is activated by low pH, inducing release of the fusion peptide (red) and dissoci-
ation of HA1 (b, orange). The relative rates of extension (kextension) and foldback (kfoldback) determine the
nature of the hypothesized fusion pathway. In the canonical productive pathway, for kextension > kfoldback
(upper row 1), coiled-coil formation in the B-loop (blue) enables HA extension and insertion of the
fusion peptide into the cell membrane (c1), followed by foldback of the hinge region (purple) and the
zippering mechanism upon unfolding of the globular domain (black) in order to overcome the dehydra-
tion barrier (d1) prior to stalk formation (e1). The fusion peptide and transmembrane domain interact
to facilitate pore formation (f1). Two alternative pathways have been proposed. For kextension < kfoldback
(middle row 2), foldback before extension enables insertion of the fusion peptides in both the virus and
cell membranes (c2), before simultaneous coiled-coil formation and zippering brings the membrane into
close contact (d2), again followed by stalk (e2) and pore (f2) formation. Non-productive refolding oc-
curs when extension happens simultaneously with foldback (kextension ≈ kfoldback, bottom row 3), giving
the fusion peptides no opportunity to insert into the target membrane (c3). Instead, they are directed
towards the viral membrane (d3), into which they insert, thereby inactivating HA (e3).
taneously with extension (kextension ≈ kfoldback), directing the fusion peptides away from
the target membrane before they can insert (Figure 2.2-c3). Irreversible insertion of the
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fusion peptides into the viral membrane, as demonstrated by unbound virions after acid-
ification,140,142 causes inactivation of HA (Figure 2.2-e3). As is clear from fusion kinetics
experiments combined with stochastic modeling, the majority of HAs may refold non-
productively,59 suggesting that kextension is indeed close to kfoldback or that other factors
hinder HA activation or fusion-peptide insertion.
There are several arguments to assume that kextension > kfoldback, thus favouring the
first pathway for productive refolding. The folding rate of a cross-linked coiled-coil dimer
is about 3× 104 s−1.30 Although the folding rate for the extension of the larger trimeric
coiled coil, kextension, would probably be somewhat lower than this, it would still be orders
of magnitude higher than the rate constant for complete HA rearrangement. In the absence
of a target membrane, the latter rate is about 5.8 s−1 at pH 4.9,80 although this value
may be different in the context of a native virion and target membrane. Furthermore,
it has been suggested that B-loop extension is guided by receptor-bound HA1,55,59 thus
increasing kextension with respect to unconfined folding. Similarly, the presence of HA1,
not modeled by Lin et al.,92,93 could hamper symmetry breaking and thereby decrease
kfoldback.
55 Finally, an HDX-MS study has shown that during activation, fusion peptide and
B-loop dynamics already increased before HA1 dissociation, essentially giving coiled-coil
extension a ‘head start’.39
2.3.3 Surmounting membrane-fusion barriers
The connection between membrane-fusion intermediates and specific conformational
states of HA is not fully clear. It has been shown that the zippering mechanism of HA
and formation of the N-cap at the end of the coiled coil deliver a significant amount of
energy for dehydration of the fusion site and stalk formation (indicated by the arrow in
Figure 2.1b),6,15,112 but the amount of energy that is available from these mechanisms
has not yet been determined. Estimates of the energy supplied by other individual fusion
proteins range from 47 to 71 kBT for HIV,
62,99 and 35 or 65 kBT from partial or complete
SNARE complex formation, respectively.38,91 Not all of this energy will be used efficiently,
so it is plausible that multiple fusion proteins will be required to surmount all the
membrane-fusion barriers shown in Figure 2.1b.
Interactions of the fusion peptide with the membrane are essential for fusion, as muta-
tions in the fusion peptide can completely inhibit fusion or halt the process at hemifusion.2
The fusion peptide can lower the barrier to stalk formation (arrow in Figure 2.1b) by in-
creasing the probability for lipid protrusions65,85 and by promoting the strong negative
curvature in the stalk by its inverted wedge shape.42,94,132 Computational studies indi-
cate that fusion peptides form transmembrane bundles117 and induce positive curvature,
thus stabilizing pores instead of stalks.37 However, the latter studies used structures de-
rived from a shorter 20 amino-acid sequence that displays a more elongated boomerang
shape,48 which could cause the difference in observations.
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The mechanism that drives stalk expansion remains unclear (question mark in Fig-
ure 2.1b). Point-like forces, such as between the transmembrane domains of SNAREs116
might exist between transmembrane fusion peptide bundles and transmembrane domains
of HA.101,117 These forces could cause a thinning and widening of the stalk.25 Hemifusion
diaphragm expansion could also be driven by increasing membrane perturbations when
fusion peptides associate with the transmembrane domains (arrow in Figure 2.1b)12,83 as
well as increased membrane tension from HAs pulling the membrane around the fusion
site.89 Finally, it has been shown that part of the transmembrane domain is necessary for
pore formation and enlargement.3,72,100
Although it is clear that the large conformational changes in HA serve to bring the two
membranes into close contact, and that the fusion peptides and transmembrane domain
play important roles in further local membrane remodeling, the molecular details and
individual energetic contributions remain elusive. We proceed by summarizing what has
been learnt about these aspects from recent experimental studies.
2.4 Stochastic modeling of influenza fusion
2.4.1 Single-particle kinetic assays
Over the last four decades, assays ranging from cell-cell and liposome-virus fusion to bio-
chemical and structural studies have greatly improved our understanding of influenza-HA-
mediated fusion.5,47 More recently, novel methods that focus on the observation of fusion
at the level of individual particles have resulted in significant new insight into the mech-
anisms of HA activity and the manner in which multiple HAs work together. For example,
single-particle tracking in cells has allowed the visualisation of the route of influenza entry
into cells7,82,84 and reconstitution of fusion of fluorescently labelled viral particles with ar-
tificial target membranes has enabled the study of fusion kinetics.22,34,58,141 Such in vitro
single-particle approaches, with their ability to control reaction conditions and their high
kinetic resolution providing important insight into the biophysically relevant aspects of
fusion, are the focus of this section.
Single-particle assays allow the observation of multiple steps in the fusion pathway
within a single experiment, for many individual virus particles simultaneously. Therefore,
rather than observing an ensemble average, the full population distribution is obtained.
Further, such single-particle trajectories provide access to short-lived intermediate states,
information that would be lost in the bulk experiments due to the asynchronicity and
dephasing of events. The analysis of single-particle data using stochastic modeling has
brought new insights of influenza fusion, which we will describe below, and has success-
fully been applied to other viral fusion systems.13,74
Bottom-up and controllable design is a key aspect of in vitro single-particle assays,
relying on the use of purified components and model membranes. In the most com-
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monly used design (Figure 2.3a), a planar supported lipid bilayer serves as the fusion
target.23,34 Assembling such a supported bilayer in a flow channel allows for a synchronous
reduction of the pH to trigger the viruses to fuse.22,34,141 The use of fluorescent tags en-
ables tracking of multiple observables simultaneously, and the low background needed for
single-particle sensitivity is achieved by employing total internal reflection fluorescence
microscopy (TIRF-M).4 The synchronous triggering of the fusion reactions is achieved by
acidification of the immediate environment and monitored by the use of a pH-sensitive
probe (Figure 2.3b). With a lipophilic dye incorporated in the virus membrane, the asso-
ciation of viral particles with the target membrane can be directly visualised. Such experi-
ments have demonstrated the rolling of influenza particles along the membrane under the
force of the flow, and the subsequent cessation of this movement (Figure 2.3c). These two
events have been interpreted as the weak association of HA1 with sialic-acid membrane
receptors and the insertion of the fusion peptide into the membrane, respectively.58 Escape
of the dye into the target membrane indicates lipid mixing and reports on the formation of
a hemifusion state (Figure 2.3d). By encapsulating an aqueous dye inside the virus, pore
opening can be detected when the content label dissipates into the space underneath the
supported lipid bilayer (Figure 2.3e). Other possible readouts are the stoichiometry of the
fusion proteins or their inhibitors (Figure 2.3f), and the ordering phase of the target mem-
brane.148 Future extensions may be able to clarify the full sequence of events from docking
to genome release, by tagging the viral capsid or genome. Multi-colour alternating laser
excitation (ALEX)63 could enable the simultaneous readout of more observables.
2.4.2 Influenza fusion mediated by a cluster of stochastically inserted
hemagglutinins
Measurements of the time elapsed between acidification and hemifusion for single in-
fluenza particles showed a rise-and-decay distribution (Figure 2.3d), with the mean fusion
time shortening with decreasing pH.22,34,56 Also, the arrest times for the particles to stop
rolling exhibit a rise-and-decay distribution (Figure 2.3c).58 This non-single-exponential
behaviour indicates that attaining arrest and hemifusion is not a single-rate process, but
rather requires multiple steps of comparable rates to complete. The observations that fu-
sion is mediated by HA, that HA activation is pH dependent,29,39 and that HA can be
driven into the postfusion state by high temperature,120 have led to the development of a
model explaining the single-particle observables (arrest and hemifusion) as resulting from
stochastically inserting HAs without the necessity of inter-HA interactions. The key steps
in this model are summarized in Figure 2.4a.
Ivanovic et al.58 found that the rate-limiting step in the conformational change of HA
was fusion-peptide release. Hence, the change of HA from the prefusion to the extended
state was modeled as a transition into a deep potential well with a single energy bar-
rier. Reduction of this barrier by protonation enables the metastable HA to extend, driven































Figure 2.3: Single-particle assay and observables. (a) The ∼100-nm thin layer of laser excitation re-
sulting from total internal reflection is used to excite fluorescent labels while minimizing background
fluorescence from solution. (b) Multiple probes can be tracked concurrently for the same virus particle.
(c-f) Examples of observables taken from the literature. 34,58,109 (c) The binned distribution of times from
pH drop to arrest of single, rolling particles (associated with fusion-peptide insertion). (d) Time distribu-
tion from pH drop to hemifusion, as detected by the membrane label escaping into the target membrane.
(e) Times from hemifusion to opening of a pore, as reported by content-label escape. (f) By using tagged
inhibitors, the fusion yield (fraction of the population achieving hemifusion) was correlated with the
observed number of inhibitors bound to an individual virion. The line represents a general logistic model
with 95 % confidence bands. 109
by thermal fluctuations. This model defines HA insertion by a single pH-dependent rate
kinsert(pH), and was able to quantitatively explain available data.149
The observations from the single-particle assays can be summarized as follows. Under
low-pH conditions and hydrodynamic flow associated with the acidic buffer exchange, the
virus particle rolls along the surface, forming and breaking weak receptor bonds, followed
by HAs extending and inserting into the target membrane. The contact patch interacting
with the target membrane is estimated to contain M = 50−150 HAs, depending on particle
geometry.58 A certain number of inserted HAs within this patch, Narrest, arrests the particle
by providing sufficient anchoring. The arrest distribution then arises as the convolution of
the single-exponentially distributed, independent insertions (Figure 2.4b), approximating
a Gamma distribution for M >> Narrest with rate parameter M × kinsert.58,149
Insertions continue stochastically and hemifusion ensues when a first, local cluster of
Ncluster inserted HAs has formed. The cluster contains a sufficient number of HAs that
together are able to overcome the membrane-fusion barrier. The formation of this first
cluster is regarded to immediately result in hemifusion, i.e. khemi (see Figure 2.4a) is large
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Figure 2.4: Influenza fusion modeled by HA-cluster formation after stochastic insertion, and sensitivity
to fusion inhibitors. (a) The key states of fusion: a virion is docked to receptors and rolls along the surface
while HA insertions take place stochastically in the contact patch (schematically shown as a simplified
grid of M = 19 trimers, realistic estimates are M = 50 − 150). Individual HAs insert independently
with rate kinsert, a function of pH. A certain number of insertions Narrest (example of three shown) arrests
the particle. Insertions continue until a sufficiently large local cluster Ncluster (example of three shown)
is formed. Hemifusion proceeds rapidly after cluster formation, i.e. khemi is large compared to previous
steps. Finally, a pore opens with rate kpore as directly observed (Figure 2.3e). (b) Using Narrest = 3 as
an example, the distribution of arrest times arises as the convolution of the three single-exponentially
distributed insertions, resulting in a rise-and-decay distribution. (c) The requirement to have Ncluster
inserted HA neighbours convolves over the number of insertions with their time distributions (arising
in the same way as in (b)) to form the hemifusion time distribution. (d) The graph shows the fusion
yield (the fraction of the virus population undergoing fusion) as a function of the number of fusion
inhibitors bound to individual virus particles, as modeled in. 59 Data for two different strains are shown,
differing markedly in their sensitivity to these inhibitors. The half-maximum points are indicated (dagger
and asterisk). The small number of inhibitors necessary to effectively inhibit fusion is explained by the
presence of a large fraction (2/3 to 3/4) of non-participating HAs (gray in pie charts), thought to arise
from non-productive HA pathways (see Figure 2.2). Strain one requires more inhibitors (dotted in pie
charts) to reach half-maximum fusion yield than strain two, because it has a larger fraction of productive
HAs (blue in pie charts).
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compared to that of previous steps – there is no data available separating these states.59,149
The probability distribution of the number of insertions that have happened prior to the
formation of a first, critical cluster is Gaussian for a sufficiently large contact patch M.149
The observed hemifusion distribution then results from the combination of the geometric
requirement to have formed a cluster and the time distributions of the insertions, generally
resulting in a slightly right-skewed Gaussian distribution (Figure 2.4c). After hemifusion,
a pore opens with a rate kpore,
34 as discussed in more detail in the previous sections.
Recent work indicated the presence of a large fraction of HAs that is not involved in
fusion (see Figure 2.4d),59 which is thought to arise from non-productive HA refolding
pathways (as described in the previous section). Single-particle experiments with tagged
HA-binding inhibitors (antibody fab fragments)109 showed that the number of inhibitors
required to reach half-maximum fusion yield is a small fraction of the total number of
HAs on a virus particle (Figure 2.4d, right pie charts). Furthermore, two influenza strains
differed markedly in their response to such inhibitors (Figure 2.4d, graph). Both observa-
tions are explained by assuming a large fraction of non-productive HAs in the native virus,
where for some strains fewer inhibitors are necessary to effectively inhibit fusion because
of an even larger non-productive fraction. Different strains also appear to require different
cluster sizes to overcome the membrane hemifusion barrier,24,59 additionally influencing
the sensitivity to fusion inhibitors.
The details have not yet been resolved, but the cluster size, fraction of non-productive
HAs, and HA activation rate seem to be system parameters which influenza may vary
under evolutionary pressures to achieve efficient cell entry, while at the same time avoiding
immunogenic detection and maintaining stability outside of the cell.
2.5 Future directions
In improving our understanding of influenza-HA-mediated membrane fusion, the combina-
tion of single-particle experiments and stochastic modeling has enabled the identification
of several important parameters, such as the independence of HA triggering by low pH and
the action of multiple HAs in a cluster to catalyze hemifusion. Non-productive pathways
of HA refolding appear to play an important role, as probed with neutralizing antibodies.
These parameters of influenza fusion can be described in a unified way and this approach
allows us to appreciate the strategy of viral fusion, or even fusion catalysis in general: the
large membrane-fusion barrier is conquered by first overcoming small kinetic barriers of
the fusion proteins to insert into the membrane, after which their catalyzing capability and
energy of refolding are utilized to drive fusion. Even though details vary, this mechanism
appears universal across all classes of enveloped viruses13,59,74,149 and may very well be
extended to other fusion systems.
For efficient entry of viruses into cells, just like for the functioning of these cells them-
selves, the timescale at which membrane fusion occurs needs to be synchronized with other
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biological processes. As described in this review, the influence of the high kinetic barriers
of dehydration and pore formation in determining this timescale became evident from the
determination of the kinetics and thermodynamics of membrane fusion. To elucidate the
relative importance of the factors that determine these barriers, the field will benefit from
further integration of experiment and computation. However, owing to a huge variety in
system parameters (as evident from the diverging data in Figure 2.1b and Table 2.A.1 in
Appendix 2.A), there is a need for more structured, collaborative studies that coordinate
to closely mimic the parameters involved in influenza membrane fusion. By combining
insights from in vitro and in silico assays, such collaborative studies will aid direct com-
parison of membrane-fusion barrier heights between different approaches, and can further
determine the relative importance of lipid composition, initial curvature, membrane ten-
sion and in particular fusion protein mediation between fusion intermediates.
To accomplish such future studies, high-resolution experimental assays have become
available that have proven to be powerful tools for access to intermediate states in the
pathway to fusion, especially when augmented by modeling approaches. Emerging exper-
imental tools are cryo-EM/ET,19 HDX-MS,33,40 fluorescence microscopy104,110 and single-
molecule force spectroscopy52,62,146 as well as combinations thereof.127 Meanwhile, com-
putational approaches become more powerful in time and length scale,31 while novel com-
putational111,113,136 and analytical32 methods can probe free-energy landscapes governing
protein conformational changes. With these tools, the synergy between experimental and
theoretical approaches at the molecular level has come within reach. Increasing the com-
plexity of in vitro and in silico assays towards in vivo conditions, one step at a time, will
lead to a better understanding of the factors governing influenza fusion, and ultimately of
all membrane fusion in living cells.
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2.A Appendix: Tables
Table 2.A.1: Overview of membrane-fusion barrier height estimates. Acronyms and abbreviations used:
(HD) Hemifusion diaphragm; (C) Curved; (F) Flat; (V) Vesicles; (chol) Cholesterol; (MFT) Mean-field
theory; (SCFT) Self-consistent field theory; (DPD) Dissipative particle dynamics; (SM) String method;
(Bulk) Bulk fluorescence microscopy; (X-ray) X-ray diffraction; (OTB) Optical tweezers using beads;
(EB) Electrical breakdown.








































































































Coarse-grained molecular dynamics (CG-MD)
CG-MD 66 POPE C/C 7.5 1 - 13 13 18 16 - -
CG-MD 66 POPE:POPC 1:1 C/C 7.5 14 14 15 13 - - -
CG-MD 66 POPE:POPC 1:2 C/C 7.5 1 - 17 15 15 13 - -
CG-MD 107 ? F/F - ? - 16 - - - - -
CG-MD 131 POPC F/F - 5/lipid - 20 - - - - -
CG-MD 101 DPPC V 6.5 1 29 - - - - - -
CG-MD 101 DPPC:DPPE 3:1 V 6.5 1 - 24 - - - - -
CG-MD 101 DOPC V 6.5 1 - 20 - - - - -
CG-MD 101 ASTail V 6 1 - 78 - - - - -
CG-MD 70 DOPC:DOPE 1:1 F/F - 4 36 - - <0 65 >0 -
CG-MD 116 POPE C/C 10 - - - 17 - - - -
CG-MD 116 POPE+30mol% chol C/C 10 - - - 24 - - - -
CG-MD 69 DMPC:DOPE 1:1 C/C 5 6.1 31 - - - 35 <0 -
CG-MD 69 DMPC:DOPE 1:1 C/F 5 6.1 38 - - - 55 <0 -
CG-MD 69 DMPC:DOPE 1:1 F/F - 6.1 42 - - - 93 >0 -
CG-MD 135 ? F - - - - - - - - 15-20
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Table 2.A.1: (Continued from previous page.)









































































































MFT 67 ‘biological lipids’ F/F - 1.5 13 - 25-63 <0 - - -
MFT 68 ‘biological lipids’ F/F - 1.5 13 - 25-63 - - - 40
SCFT 86 POPE:POPC 2:3 vol F/F - 2 16 - 16 <0 - - -
SCFT 86 POPE:POPC 2:3 vol F/C 14.7 2 16 - 5 <0 - - -
SCFT 86 POPE:POPC 2:3 vol F/C 9.8 2 16 - 4 <0 - - -
SCFT 86 POPE:POPC 2:3 vol C/C 3.7-9.8 2 13 - -26 <0 - -
DPD 45 ? C/F 7 1.5 8 - 11 8 - - -
DPD 45 ? C/F 14 1.5 8 - 14 8 - - -
SCFT+SM 27 Low tension F - - - - - - - - 90
SM 103 ‘biological lipids’ F/F - 1.2 16 -3 - - - - -
Continuum elasticity theory
Continuum 81 ? dimples 10 0.8 - 37 - - - - -
Continuum 79 DOPC F/F - 6.2 45 - - - - - -
Continuum 79 DOPE F/F - 6.2 -30 - - - - - -
Continuum 95 ? ? ? ? - 55 40 - - - -
Continuum 60 DOPC F/F - 3 - - - - - - 54
Continuum 121 DOPE:DOPC/S 1:1/5 F/F - 3-5 27 - 31 35 120 <0 45
Experiment
BFM 90 DOPC:DCPC 85:15 V ? <1 - 29 33 33 - <0 -
X-ray 1 DOPC F/F - 1.5 173 - - - - - -
X-ray 1 DOPC:DOPE 1:1 F/F - 1.5 89 - - - - - -
X-ray 1 DOPC:chol20% F/F - 1.5 55 - - - - - -
OTB 108 PC:PE:PS:chol 6:2:1:1 F/C 750 <1 - 30 14 - 14 - -
EB 43 ? (asolectin) F - - - - - - - - 45
X-ray 114 DOPC F/F - - 199 - - - - - -
X-ray 114 DOPC:DOPE 1:1 F/F - - 101 - - - - - -
X-ray 114 PC:PE 1:1+chol F/F - - 84 - - - - - -

3
CHARMM TIP3P water model suppresses peptide folding
by solvating the unfolded state
Abstract
The accuracy of molecular dynamics simulations depends on the underlying force field, de-
fined by the form and parametrization of the interparticle potential functions and the wa-
ter model. The treatment of the solvent is crucial in molecular dynamics force fields, as hy-
drophobic interactions and hydrogen bonding are important molecular forces. The widely
used CHARMM force field was originally parametrized using a modified version of the
TIP3P water model (mTIP3P), including Lennard-Jones interactions between hydrogens
and oxygens. The latest version, CHARMM36, was optimized using the standard TIP3P
water model (sTIP3P) for proteins, while mTIP3P is still being used for lipids. Our replica
exchange molecular dynamics simulations on dynamic peptides show that the CHARMM36
force field with mTIP3P water yields less realistic folding than with sTIP3P water. Analysis
of the dimensions and hydrogen bonding of the unfolded state reveals that the peptides are
more solvated and extended in mTIP3P, due to a higher solvation energy of the peptide in
this water model. We recommend using CHARMM36 with sTIP3P when simulating pep-
tides, folded proteins, and natively unfolded proteins, but combinations of proteins with
lipids would require a reparametrization to make their water models compatible.
Reprinted with permission from Boonstra S, Onck PR, van der Giessen E. 2016. CHARMM TIP3P water model
suppresses peptide folding by solvating the unfolded state. J. Phys. Chem. B 120:3692–3698. Copyright 2016
American Chemical Society. DOI: 10.1021/acs.jpcb.6b01316
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3.1 Introduction
Molecular dynamics force fields are widely used in simulations of biomolecular systems.
Modern force fields have been shown to accurately reproduce properties of small pep-
tides3,12 and folded proteins.22 However, the unfolded state has been shown to be much
more collapsed than found in experiments, indicating that the propensity to structure for-
mation is overestimated.32 Force field potentials have recently been modified to better
represent the equilibrium between folded and extended conformations5,10,17 by counter-
acting a bias toward helical conformations.4 This helix–coil equilibrium is determined by
the balance between the intramolecular energy of a helical state and the solvation energy
of more extended states.1 For the accurate hydration of hydrophobic groups, the interplay
between the protein force field and the water model plays a central role.6
CHARMM36,10 the latest version of the CHARMM potential set for proteins, is the
product of a recent reparametrization aimed at improving the balance between the sam-
pling of helical and extended conformations. It was optimized using the standard TIP3P
water model (sTIP3P),19 whereas previous versions of CHARMM used a modified version
of TIP3P (mTIP3P).23 This modified version includes Lennard-Jones potentials on the hy-
drogen atoms of water, making them interact with both the solute and the solvent.30 These
interactions are absent in sTIP3P.
Studies with the Amber force field have shown that the use of an alternative water
model can significantly influence the helix–coil equilibrium.6,31 Since the CHARMM pa-
rameters for lipids20 have been obtained using mTIP3P water, simulations that include a
combination of proteins or peptides with lipids will have to be performed in mTIP3P water.
However, this could lead to a shift in the helix–coil equilibrium, which was balanced using
sTIP3P water. To explore this, we studied the influence of both water models on the helix–
coil equilibrium in peptides as predicted by CHARMM36. The results of our study can have
implications for all studies on peptides, proteins, and lipid systems using the CHARMM36
force field with one of the two TIP3P water models.
3.2 Method
Replica exchange molecular dynamics (REMD) simulations were used to sample the con-
formational space of the 3K(I)26 and AQ35 α-helical peptides and of the GB129 β-hairpin.
AQ and GB1 have been used in the parametrization and validation of the CHARMM36
force field, while 3K(I) was selected to have an independent reference. In the remainder
of the text, "folded fraction" is used interchangeably with helical fraction, depending on
the peptide. All simulations were carried out using GROMACS 4.6.16
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3.2.1 Water models
The water models used in this study are the standard TIP3P as published by Jorgensen
et al. (sTIP3P)19 and a modification of TIP3P (mTIP3P) that was employed during the
parametrization of an earlier version of the CHARMM force field.23 To avoid singularities
in the computation of the integral equations, mTIP3P introduced Lennard-Jones interac-
tions on the hydrogen atoms (HT) of water molecules by setting σHT = 0.04 nm and
"HT = 0.1925 kJ/mol, instead of σHT = 0 nm and "HT = 0 kJ/mol as used in sTIP3P.30
The other force field parameters, including those of the water oxygen atoms, are identical
in both water models.
3.2.2 System setup and equilibration
The 3K(I) (Ace-(AAAAK)3A-NH2), AQ (Ace-(AAQAA)3-NH2), and GB1 (GEWTYDDATK-
TFTVTE) peptides were prepared in an extended conformation. The topologies were cre-
ated using the GROMACS tool pdb2gmx and included the CHARMM CMAP correction. In
agreement with the experiments, the N- and C-termini of 3K(I) and AQ were acetylated
and amidated, and those of GB1 were charged. Ionizable residues were protonated accord-
ing to pH 7. After a steepest descent energy minimization, the peptides were solvated in
a truncated octahedral box with 2379, 2393, and 1834 molecules, respectively, of either
sTIP3P or mTIP3P water. If needed, chloride or sodium atoms were added to neutralize the
system. The simulation box was then energy minimized again using the steepest descent
algorithm, followed by an equilibration run of 200 ps at 200 K using the Langevin thermo-
stat, with position restraints on the peptide to relax the solvent. The temperature was set
to 300 K with a 100 ps run in the NVT ensemble, after which an NPT simulation of 200 ps
set the pressure to 1 bar using Berendsen pressure coupling. The resulting simulation box
was scaled to the average volume of the last 50 ps.
3.2.3 Replica exchange molecular dynamics
REMD enhances sampling by exploiting the fact that energy barriers can be overcome
more easily at higher temperatures and provides an ensemble average as a function of
temperature. REMD simulations were run using 32 replicas in the NVT ensemble with
temperatures ranging from 275 K to 427 K and replica exchange attempts every 1 ps. An
NVT run of 100 ps was used to equilibrate each replica at the desired temperature. This
resulted in exchange probabilities ranging from 0.25 to 0.4. Langevin integration was
used with a friction coefficient of 0.2 ps−1. The Langevin thermostat slightly influences the
dynamics but does not affect the averages taken in equilibrium conditions.2 A time step of
2 fs has been used while constraining all bonds including hydrogen atoms with P-LINCS15
and keeping the waters rigid using SETTLE.28 Long-range electrostatics was calculated
using PME with a grid spacing of 1.2 Å and a direct space cut-off of 9 Å. The van der Waals
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interactions were cut off at 14 Å. This runs faster than standard CHARMM settings, i.e., a
switching function between 10 and 12 Å, but yields similar results. The REMD run times
ranged from 500 ns to 1.1 µs, depending on the peptide and the water model.
3.2.4 Definition of folded states
Coordinates were stored every 1 ps for analysis of the peptide structure, solvation, and
hydrogen bonding. A residue is regarded to be in a helical conformation if its backbone
dihedral angles φ ∈ [−100◦,−30◦] and ψ ∈ [−67◦,−7◦].13 The helical fraction of a con-
formation is defined as the number of consecutive residues (at least three) in a helical
conformation divided by the number of residues in the peptide. For 3K(I) and AQ, a con-
formation with zero helical fraction is called unfolded. A conformation of the GB1 peptide
is regarded as being folded if the dRMS with respect to all native contacts in the PDB struc-
ture (PDB: 1GB1) is smaller than 1.5 Å.7 Native contacts lie between backbone atoms
(CA, C, O, and N) with a maximum distance of 4.5 Å, but only for residues separated by
at least two other residues in the sequence. The melting curves show the average helical
or folded fraction over all conformations, with the error calculated as the sum of the inter-
and intrablock standard error of the mean using five blocks. The cut-offs for identifying
hydrogen bonds were a 3.5 Å distance and a 30◦ angle.
3.2.5 Convergence
All the performed simulations have converged to the equilibrium ensemble as monitored
by the evolution of the helical or folded fraction. Figure 3.1 illustrates this for the case of
the helical content of AQ at 275 K (similar convergence was obtained for 3K(I) and GB1).
The replicas at higher temperatures generally equilibrate faster and were analyzed from
the starting point of the lowest temperature replica. The unbiased converged averages




The temperature dependence of the folded and helical fractions resulting from the sim-
ulations are shown in Figure 3.2, together with experimental values from the literature.
Both the folded and helical fractions from the simulations using sTIP3P are consistently
higher than those from the simulations using mTIP3P. CHARMM36 was parametrized to
yield agreement with the experimental helical fraction of AQ at 300 K,10 so absolute com-
parison between the water models should be made at this temperature. In doing so, sTIP3P
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Figure 3.1: Convergence of the helical fraction of the AQ peptide at 275 K. The running average, for the
sTIP3P (blue) and for the mTIP3P (red) water model, uses a 3 ns window and starts at 0 ns, while the
cumulative average (black) and backward cumulative average (purple) ignore the equilibration data.
lies much closer to the experimental value at 300 K than mTIP3P, for both 3K(I) and GB1.
The difference in the free energy of unfolding of 3K(I) between the two water models is
about 4 kJ/mol at 275 K (see Figure 3.3).
The melting curves of AQ using sTIP3P or mTIP3P, shown in Figure 3.2b, lie on opposite
sides of the experimental curve at lower temperatures, with deviations of 0.13 and −0.07
at 300 K. Figure 3.2b also shows the melting curve from a 50 ns run (after subtracting 100
ns equilibration time) with CHARMM36 and sTIP3P, produced by Best et al.8 using a 2 ps
exchange frequency. The helical fraction at 300 K from this run corresponds well with the
helical fraction from the experiment. However, even for an equilibrated system of replicas,
a 50 ns window might not be sufficient to determine an accurate average helical fraction.
This can also be seen from the ruggedness of the Best et al.8 melting curve, indicating
that not all replicas have reached their equilibrium ensemble. In our simulations, using an
even higher exchange frequency, an average helical fraction anywhere between 0.3 and
0.6 could be obtained when using a 50 ns window at distinct points after the equilibra-
tion (Figure 3.1). This illustrates the need for a longer time window to obtain an accurate
average. The blue crosses in Figure 3.2a show that switching off the van der Waals poten-
tial between 10 and 12 Å yields results similar to the plain cut-off at 9 Å that was used
otherwise.
3.3.2 Characteristics of the unfolded state
The parametrization of the CHARMM36 force field10 was partly intended to rebalance
the equilibrium between helical and extended conformations. In a search for the reason
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Figure 3.2: Melting curves for the three tested peptides using the CHARMM36 force field combined with
the sTIP3P (blue) and mTIP3P (red) water models. The crosses in (a) show the results using a van der
Waals potential that is switched off between 10 and 12 Å interaction distance, instead of the 9 Å cutoff.
The open circles in (b) show the result obtained with CHARMM36 and sTIP3P by Best et al. 8 The vertical
dashed line at 300 K is drawn as a guide to the eye. Experimental results (black) from circular dichroism
of 3K(I) 26 (a), NMR chemical shifts of AQ 35 (b), and tryptophan fluorescence of GB1 29 (c).
underlying the differences seen above, we explore the effect of each of the water models
on this balance. This effect is largest in the unfolded conformations, so we investigated
these for the 3K(I) and GB1 peptides. The results for AQ (not shown) are similar to those
for 3K(I) presented here.
Consistent with the results in Figure 3.2a, the unfolded 3K(I) peptide tends to more
extended conformations in mTIP3P than in sTIP3P, as can be seen from the radius of gy-
ration RG of 3K(I) in Figure 3.4a (•, left axis). This suggests that unfolded molecules in
mTIP3P tend to be more solvated, which is confirmed by a higher solvent accessible sur-
3.3 Results 47
















Figure 3.3: Free energy of unfolding for the 3K(I) peptide using the CHARMM36 force field combined
with the sTIP3P (blue) and mTIP3P (red) water models, calculated using ∆GU =−RT ln[(1− xH)/xH]
with xH the helical fraction. The vertical dashed line at the experimental melting point (286 K) is drawn











































(a) 3K(I) is more extended in mTIP3P.








































(b) 3K(I) has more backbone-backbone hydrogen bonds
in sTIP3P.
Figure 3.4: Analysis of the unfolded conformations of 3K(I) for both water models (mTIP3P in red,
sTIP3P in blue). (a) Radius of gyration (•, left axis) and solvent accessible surface area (É, right axis).
(b) Hydrogen bond formation between backbone and solvent (•, left axis) and within the backbone (É,
right axis). The vertical dashed line at 300 K is drawn as a guide to the eye. The symbols are larger than
the errors.
face area (SASA) of the unfolded peptide in this water model (Figure 3.4a, É, right axis).
The RG of the unfolded state of 3K(I) can be compared to that of an almost identical pep-
tide called AK16 (YGAAKAAAAKAAAAKA), measured to be 0.98 nm at room temperature
in 4 M urea.21 The RG of 3K(I) in sTIP3P at room temperature is 0.99 nm, which lies
significantly closer to the experimental value than the RG of 1.10 nm in mTIP3P.
The higher solvation of the unfolded peptide in mTIP3P compared to sTIP3P can be
48 3. CHARMM TIP3P water model suppresses peptide folding
explained by stronger hydrogen bonding between the backbone and the solvent, as can be
seen from the higher amount of backbone–solvent hydrogen bonds in Figure 3.4b (•, left
axis). There is also less hydrogen bonding within the backbone of the peptide in mTIP3P
(Figure 3.4b, É, right axis) and consequently a less compact conformation. The RG re-
duces with increasing temperature in both water models (Figure 3.4a). This corresponds
to a slight increase in the number of backbone-backbone hydrogen bonds (Figure 3.4b),
indicating collapse of the unfolded state by formation of secondary structure.










































(a) GB1 is more extended in mTIP3P.







































(b) GB1 has more backbone-backbone hydrogen bonds
in sTIP3P.
Figure 3.5: Analysis of the unfolded conformations of GB1 for both water models (mTIP3P in red,
sTIP3P in blue). (a) Radius of gyration (•, left axis) and solvent accessible surface area (É, right axis).
(b) Hydrogen bond formation between backbone and solvent (•, left axis) and within the backbone (É,
right axis). The vertical dashed line at 300 K is drawn as a guide to the eye. The symbols are larger than
the errors.
The characteristics of the unfolded state of the GB1 hairpin look slightly different from
the α-helical peptides, but the overall trend is the same. GB1 is also more extended and
solvated in mTIP3P than in sTIP3P, as can be seen from the RG and SASA in Figure 3.5a.
Again, the number of backbone–solvent hydrogen bonds in Figure 3.5b (•, left axis) in-
dicate that the higher solvation of the peptide in mTIP3P is due to stronger hydrogen
bonding between the peptide and the solvent. Unlike the helical peptides, the β-hairpin
does not show a collapse of the unfolded state in sTIP3P (Figure 3.5a). Inspection of the
unfolded conformations of GB1 in sTIP3P shows that they are on average relatively com-
pact because of a high amount of misfolded hairpins at low temperatures. This corresponds
to the relatively high number of backbone-backbone hydrogen bonds, which gradually de-
crease with temperature (Figure 3.5b, É, right axis).
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3.4 Discussion
In the parametrization of the CHARMM36 force field, the backbone and side-chain dihe-
dral angles were optimized in two separate steps. The simulations were done on several
biomolecular systems that were solvated by either the sTIP3P or mTIP3P water model,
depending on the molecular dynamics software used.10 For instance, the backbone opti-
mizations were performed using Ala5 in mTIP3P and AQ in sTIP3P, with feedback from
crystal simulations of folded proteins in mTIP3P. Side-chain optimizations were guided by
simulations of unfolded GB1 and ubiquitin in urea and sTIP3P, as well as crystal simula-
tions of proteins using mTIP3P. Validations have been carried out for several folded and
unfolded proteins, using either sTIP3P or mTIP3P. Our results, however, show that there
is a significant difference in the stability of helical and folded states between the two wa-
ter models, which affects the applicability of the force field and water model to specific
biomolecular systems.
There are other studies on peptides in the literature, in which the default water model
has been replaced by an alternative one. A combination of Amber ff99SB with the TIP4P-
Ew water model led to results that are consistent with those presented here.31 The more
extended unfolded conformations showed increased backbone–solvent hydrogen bonding
which led to a significantly lower folded fraction of the Trp-cage miniprotein compared to
that with the sTIP3P water model. The result of the sTIP3P simulation was recovered from
the TIP4P-Ew simulation by reducing the backbone–solvent hydrogen bond strength. It was
noted that enhancing the intramolecular peptide–peptide hydrogen bonds or strengthen-
ing the backbone dihedral potentials would lead to the same result. Such a rescaling stabi-
lizes the folded state and increases the fraction of folded conformations at lower tempera-
tures. Similarly, we expect that the helix–coil equilibrium for CHARMM36 in combination
with mTIP3P could be restored by rescaling the hydrogen bond strength or readjusting the
backbone dihedral potentials.
Another example of using an existing force field with a different water model is the
optimization of Amber ff03w in combination with the TIP4P/2005 water model.6 For this
force field, the dihedral potentials of Amber ff03* were optimized against scalar couplings
measured for Ala5 and AQ. The resulting melting curve showed a higher helical fraction
and increased cooperativity of folding using ff03w with TIP4P/2005, while the peptide
was overall more extended than in ff03* with sTIP3P. Further analysis showed that the
difference is related to a more favourable enthalpy of solvation in TIP4P/2005. In our
simulations with CHARMM36, the peptides are more solvated in mTIP3P than in sTIP3P.
In analogy to the results with Amber ff03w, we hypothesize that rebalancing the dihedral
potentials of CHARMM36 for peptides solvated in mTIP3P could increase the amount of
helical fraction and improve the cooperativity of helix formation with respect to our results
in sTIP3P.
Further work on the Amber ff03w force field, resulting in the Amber ff03ws force field,
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involved scaling of the Lennard-Jones interactions between atoms of the solute and oxygen
atoms of the water molecules.9 This scaling induced the intended reduction of protein–
protein affinity, but also reduced the helical propensity of AQ in comparison with ff03w.
This illustrates that increasing protein–solvent interactions involving the solvent oxygen
atom can lead to a destabilization of the folded state, similar to the effect of the added
interactions on solvent hydrogen atoms shown here in mTIP3P.
A recent comparison of force fields on the intrinsically disordered RS (24 residues)
and FG-nucleoporin (16 and 50 residues) peptides has also shown that the combination
of CHARMM36 with mTIP3P results in a more expanded peptide, with an RG of the RS
peptide that is about 1 Å larger than in sTIP3P.34 This agrees with the difference in RG that
we found between the two water models for the three tested peptides of similar length.
They have also found a high population (about 40%) of residues in a left-handed α-helical
(αL) conformation for the RS peptide in both water models. In the subsequently tested
A3 and AQ peptides, αL was shown to be only 7%. This is consistent with our results, in
which αL ∼ 5− 7 % (data not shown). Apparently, the secondary structure of intrinsically
disordered peptides is not well-represented in CHARMM36 with either mTIP3P or sTIP3P,
while peptides with more preference for a certain secondary structure are best represented
when combined with sTIP3P.
The differences between the sTIP3P and mTIP3P water models are not substantial for
simulations of proteins in their native, folded state. Backbone and side-chain NMR data
have been compared with data from simulations in sTIP3P10 and in mTIP3P,10,18 both
showing good correlation with experimental data. In the latter publication, utilization of
mTIP3P was not declared specifically but confirmed to us by the authors (private communi-
cations). The water models also show negligible differences in the RMSD of folded proteins
when combined with CHARMM27, the previous version of the force field.11 Additionally, a
force field comparison on folded proteins27 reports little difference between the balanced
and unbalanced (previous) versions of two Amber force fields. The native state of a folded
protein in solution sits in a global free energy minimum that is apparently not affected
much by the differences in solvation energy between the two water models. From this,
we conclude that proteins with a low surface to volume ratio, which are consequently not
highly solvated, can accurately be simulated using either of the water models. However,
proteins with a high surface to volume ratio are expected to be influenced significantly by
the water model.
For all molecular dynamics force fields, the parametrization conditions and settings are
as much a part of the force field as the interaction potentials themselves. It is well-known
that the water model is also an integral part of the parametrization.23,24 Although the
differences between the sTIP3P and mTIP3P water models are small in terms of bulk prop-
erties11,25 and simulations of folded proteins, we have shown that they have a significant
effect on the folding of small dynamic peptides. For these systems, CHARMM36 should
best be used with sTIP3P, the water model it was parametrized with. Although there is
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little difference between the two water models for simulations of folded proteins, we still
recommend using sTIP3P because it reduces computational cost.
The CHARMM36 force field for proteins is often used for simulations including nucleic
acids14 or lipids.20 The parameter set for nucleic acids has been optimized using sTIP3P,
so combinations of proteins and nucleic acids can be readily simulated in sTIP3P water.
For lipids, however, CHARMM36 was parametrized in combination with the mTIP3P water
model. Using sTIP3P for a DPPC bilayer results in a significant underestimation of the area
per lipid, with the bilayer transitioning into a tilted gel phase. This artifact occurs in partic-
ular when using the GROMACS switching function for the Lennard-Jones potential, which
switches off the potential energies instead of the forces.33 Hence, a combination of lipids
with small dynamic peptides or natively unfolded proteins results in a conflict between the
preferred water models and therefore requires reparametrization or rebalancing of one of
the parameter sets to make them compatible with the water model used.
3.5 Conclusion
Comparison of the sTIP3P and mTIP3P water models using REMD on small dynamic pep-
tides simulated with the CHARMM36 force field shows a better agreement with experi-
mental melting curves if sTIP3P is used. The use of mTIP3P results in a more solvated and
extended unfolded state, which in turn leads to a lower fraction of folded conformations.
This appears to be due to a higher solvation energy of the peptide in this water model,
shifting the balance from folded states toward more extended states.
For simulations of less dynamical systems, such as folded proteins in their native state,
CHARMM36 could still be used in combination with mTIP3P water. This also holds for
simulations that include lipids or nucleic acids. However, also regarding computational
efficiency, we recommend using CHARMM36 in conjunction with sTIP3P when simulating
small peptides, folded proteins, and dynamic or intrinsically unfolded proteins. The com-
bination of dynamic peptides or proteins with lipids, parametrized using mTIP3P, requires
a reparametrization to make the water models compatible.
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Critical interactions in the globular bottom of influenza
hemagglutinin
Abstract
Influenza hemagglutinin (HA) mediates fusion of the endosomal and viral membranes
during viral invasion. Single-particle experiments have indicated that half of the available
HAs are non-productive in the fusion process, presumably by a collapse of the fusion-active
subunit (HA2) before insertion of its amphipathic fusion peptides into the target mem-
brane. As such, the balance between the rates of insertion and collapse seems to determine
HA productivity. By mechanical unfolding of the globular bottom of HA2, we investigated
which molecular interactions in HA control the rate of collapse. We find Arg163 as a criti-
cal residue within a network of stabilizing salt bridges in the core of the globular bottom.
Preliminary results from single-particle experiments are consistent with the hypothesis that
the number of non-productive HAs increases when mutations disturb this network. How-
ever, further experiments are needed to examine if other effects of the mutations might
impact fusion efficiency. The regulation of fusion efficiency through targeting conserved
residues, such as the ones found here, can potentially be used as a generic antiviral strat-
egy.
Boonstra S, Blijleven JS, Ivanovic T, Onck PR, van Oijen AM, van der Giessen E. Critical interactions in the
globular bottom of influenza hemagglutinin. In preparation.
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4.1 Introduction
The traffic of biological cargo between cells and between intracellular compartments relies
on the presence of pores, which can be either inherent to the cell membrane or formed
by membrane fusion. This latter mechanism unifies individual compartments by joining
together their delineating membranes. Although lipid bilayer fusion is thermodynamically
favourable, the end states are separated by a high kinetic barrier.11 Various biological pro-
cesses have evolved their own specialized fusion proteins to overcome this barrier within
a biologically relevant timescale. Examples include synaptic vesicle fusion in neuron trans-
mission by SNARE proteins,39 fusion in the endoplasmic reticulum by GTPases22 and fu-
sion by viral fusion proteins during viral entry.19,27 Of the latter, influenza hemagglutinin
(HA) is the most thoroughly characterized. Both its prefusion47 and postfusion8 structure
were the first to be crystallized of all fusion proteins. The amount of knowledge already
acquired about HA, and the strong resemblance of its postfusion structure with those of
other fusion proteins, has made it a popular model system to study the operating mech-
anism of other fusion proteins.33,43 A hypothesized pathway for HA-mediated fusion has
been inferred from the conformational differences between the pre- and postfusion crystal
structures, backed up by biochemical experiments.5 HA is a homotrimeric glycoprotein
that is embedded in the membrane of a virus particle through a transmembrane domain.
Upon cleavage, each monomer reorganizes into two domains, HA1 and HA2, that are con-
nected by disulfide bonds, as shown in Figure 4.1a. The globular HA1 domain can bind to
receptors on the plasma membrane (Figure 4.1b), after which the virus particle is inter-
nalized by endocytosis. Acidification of the endosome to a pH below 6 activates the fusion
process, by dissociating HA1 and exposing hydrophobic fusion peptides at the N-terminal
of the fusion domain, HA2 (Figure 4.1c).14 The pathway shown in the top row of Figure
4.1 is characterized by a timely transition of the previously unstructured B-loop of HA2
into a helical coiled coil, extending the central coiled coil. This facilitates insertion of the
fusion peptide into the target membrane (Figure 4.1d).9,44 The putative ‘extended inter-
mediate’ that is formed this way, bridges the two membranes. Subsequent collapse of the
globular bottom of HA2 transforms the protein into a hairpin that is hypothesized to pull
the membranes together in a zipper-like fashion (Figure 4.1e) for productive membrane
fusion (Figure 4.1f).10,37
A combination of single-particle fusion kinetics experiments36 and stochastic modeling
of HA activation and insertion has led to the notion that a large fraction of HAs does
not participate productively in the fusion process.25 Instead, fusion is mediated by only
a certain number of productively inserting HAs that can jointly provide enough energy
to make the membranes fuse.24 The number of HAs required for fusion, their activation
rate and the fraction of non-productive HAs varies between virus strains. Two HA strains
that show a marked difference in these properties are H1 and H3,36 which belong to two
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Figure 4.1: a) Structure of one monomer of hemagglutinin (HA) in cartoon representation, with HA1
in light brown and colour-coded regions in HA2: 1-23 cyan (fusion peptide); 24-57 gray; 58-75 blue
(B-loop); 76-105 gray; 106-128 purple (hinge region); 129-175 yellow (globular bottom), with 146-
154 green (helix G) and 163-171 red (helix H). Residues Asp90 and Asp112 are indicated in licorice
representation in red. b-f) Proposed productive and non-productive fusion pathways. b) HA binds to the
target membrane on sialic-acid receptors (dark brown). c) Low pH induces dissociation of HA1 subunits
(light brown) and release of the fusion peptide (cyan). In the proposed productive pathway (top row,
d), the loop-to-helix transition in the B-loop (blue) enables the fusion peptides to insert into the target
membrane before (e) the collapse of the trimer in the ‘hinge‘ region (purple), unfolding and zippering up
of the globular bottom (yellow), leading to (f) fusion. The hypothesized non-productive pathway (bottom
row, d) is induced by a premature collapse of the hinge region (purple) and unfolding and zippering up
of the globular bottom before insertion of the fusion peptides in the target membrane. Instead, after
extension of the central coiled coil (e), the fusion peptides are inserted into the viral membrane (f),
effectively inactivating the protein.
strains has been proposed to be a host-specific evolutionary mechanism to optimize the
location of the fusion event as close as possible to the cell nucleus, at the risk of detection
by the host immune system and lysosomal degradation.12,25,41 However, the molecular
mechanism that the virus employs to tune HA productivity remains unclear.
We here explore a possible role for the globular bottom of HA2 in governing fusion
productivity, as illustrated by the non-productive pathway of HA rearrangements in the
bottom row of Figure 4.1. The idea is that before the fusion peptides can insert into the
target membrane, the globular bottom collapses (Figure 4.1d) and the zippering mech-
anism starts (Figure 4.1e). Such a premature collapse effectively inactivates the protein
by insertion of the fusion peptides into the viral membrane (Figure 4.1f).45 The hypoth-
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esis that the productivity of individual HAs is determined by the stability of the globular
bottom is consistent with computer simulations of the pre- to postfusion transition of HA
using a structure-based model, where it was found that all other HA2 rearrangements
ensue rapidly as soon as the globular bottom has unfolded.30
To test this hypothesis, we investigated the mechanical stability of the globular bottom
of two virus strains using steered molecular dynamics simulations. We find that a network
of salt bridges in the core of the globular bottom provides stability against the applied
load in mechanical unfolding simulations. Breaking of a particular salt bridge within this
network is a critical event during the unfolding. With this knowledge, mutant viruses are
designed that do not form the critical salt bridge and which unfold significantly faster than
the wild-type in the simulations. Preliminary results from single-particle fusion kinetics




Steered molecular dynamics simulations were used to mechanically unfold the globular
bottom of HA from two influenza strains, H1 (A/Puerto Rico/8/34 (PR8) H1N1) and H3
(A/Aichi/68 (X31) H3N2, PDB code 1HGF40). These strains were selected because there is
data on the fraction of productive HAs for each of them.25,36 The structure of this specific
strain of H3 is known for HA2 residues 1-175, which can be used as a starting point for
the simulations. However, the crystal structures in the PDB database for H1 of this strain
contain at most the residues 1-160 of HA2 (PDB code 1RU7). To obtain a structure of
HA2 up to residue 175 for the simulations, a homology model of the H1 sequence of HA2
onto the structure of H3 (PDB code 1HGF) was made using the SWISS-Model web server.4
A comparison of the modeled structure with the incomplete structure of H1 is shown in
Figure 4.B.1 in Appendix 4.B.
All simulations were carried out in GROMACS 4.6,21 using the CHARMM36 force
field3 and the standard TIP3P water model.26 As our previous work has shown,7 this
water model yields more realistic propensities for folded structures in combination with
the CHARMM36 force field than the default CHARMM TIP3P water model.32 Langevin
integration was used with a friction coefficient of 1 ps−1 to maintain the temperature at
300 K. In the case of NPT simulations, the atmospheric pressure was maintained using
Berendsen pressure coupling with a coupling coefficient of 1 ps−1. The integration time
step was 2 fs, while all bonds including hydrogen atoms were constrained using P-LINCS20
while keeping the waters rigid using SETTLE.34 Long-range electrostatics was treated with
the particle-mesh Ewald (PME) approximation, using a grid spacing of 1.2 Å and a direct










Figure 4.2: Starting configuration and pulling groups for globular bottom unfolding of HA2112. The
center of mass (COM) of each of the Asp112 residues at the N-terminus are fixed at their starting
coordinates. A pulling force of 100 pN is applied to each of the C-terminal residues Gly175 individually,
in the direction parallel to the trimeric three-fold symmetry axis. The ‘top’ part (purple), Helix G (green)
and H (red) are indicated.
with our previous work.7
The starting configuration and pulling conditions for the mechanical unfolding of the
globular bottom are shown in Figure 4.2. To reduce computing time, the simulations were
carried out on a truncated model of prefusion HA2 (HA2112, containing residues 112 to
175; see Figure 4.1a). The centers of mass of the N-terminal residues Asp112 were con-
strained to their initial positions, while the C-terminal residue Gly175 was pulled for each
chain independently with a constant force. The direction of the forces is parallel to the axis
of three-fold symmetry of the HA trimer.
Due to the truncation to HA2112, the fusion peptides were removed from their positions
between the helices near Asp112 in the central coiled coil (marked red in Figure 4.1a).
Their absence could potentially introduce instabilities in the coiled coil during the pulling
simulations, which would erroneously influence the behaviour of the globular bottom. So,
in order to find the new equilibrium positions of these helices in the absence of the fusion
peptides, an equilibrium MD simulation was carried out on a slightly larger model of HA2
which includes more of the coiled coil but not the fusion peptides, (HA290, containing
residues 90 to 175; see Figure 4.1a). This showed that the average distance between the
centers of mass of Asp112 residues decreased quickly, from the initial separation of about
1.5 nm in the crystal structure, to an average equilibrium distance of approximately 1.2 nm
in the simulation without the fusion peptides. Accordingly, configurations with the centers
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of mass of all Asp112 residues separated between 1.15 nm and 1.25 nm were taken from
the simulation and were truncated at residue Asp112 to be used as initial configurations
for simulations on HA2112. An example of such a configuration is shown in Figure 4.2.
Initial configurations for pulling simulations with mutations in HA2112 were obtained using
the same procedure, starting from HA290 models that included the respective mutations.
Mutations were applied to the protein structures using PyMol.42
Another effect of the truncation to HA2112 is that the helices that belong to the central
coiled coil are now considerably shorter, thus decreasing their stability with respect to full-
length HA2. To preclude unwanted effects from coiled-coil unfolding, constraints were
applied that reinforce the helical hydrogen bonds. These constraints were implemented
by adding harmonic potentials between each backbone nitrogen atom and the carboxyl
carbon atom three residues further in the helix, with a force constant of 1000 kJ/(mol nm)
and with the distance between the atoms in the starting configuration as the reference
distance.
The applied pulling force should be high enough to unfold the globular bottom within
a reasonable amount of computing time, while at the same time, it should be low enough
to give stochastic processes in the globular bottom time for it to unfold. Exploratory pulling
simulations on HA290 at different constant pulling rates (with Asp90 as the reference group
for the pulling) have shown that at high rates, the coiled coil is being unfolded rather than
the globular bottom. Notably, the magnitude of the pulling force, on average, does not
change much in simulations with pulling rates ranging from 0.1 to 5 Å/ns. It was found
that at a maximum pulling rate of 0.2 Å/ns, the globular bottom unfolds without loss of
secondary structure in the coiled coil. The corresponding average pulling force of about
100 pN was therefore used in the constant force pulling simulations on HA2112. See Ap-
pendix 4.C for more details.
The equilibration procedure for the pulling simulations on HA2112 started with 10 000
steps of steepest descent energy minimization of each of the twenty initial configurations
(obtained as described above) in vacuum. Solvent was added to the minimized structure
to fill an over-sized triclinic box (12.6 nm× 6.4 nm× 5.6 nm), with the longest axis of the
box aligned to the pulling direction in order to provide space for the solute to unfold. The
solvated system was then energy minimized for another 10 000 steps of steepest descent.
A simulation of 100 ps was then carried out in order to relax the solvent around the solute
atoms, which were restrained at their initial positions. A subsequent NVT Langevin dynam-
ics run of 50 ps then heated the system to 300 K, followed by a 100 ps NPT run for pressure
equilibration. The positional restraints remained on the solute during these runs to main-
tain the energy minimized configuration. The resulting solvated system configuration was
used as the starting configuration for a production (pulling) run. The NVT ensemble was
used in the pulling simulations, because GROMACS could not handle pulling distances
larger than half the box size in the NPT ensemble. During production runs, protein coor-
dinates were saved every 1 ps for analysis.
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The equilibration procedure for the equilibrium MD simulations on HA290 was the
same, albeit that HA290 was solvated in a truncated dodecahedral box, sized to main-
tain a minimal distance of 5 Å between the protein and all periodic box walls. Also, the
production runs of HA290 were carried out in the NPT ensemble to rule out effects from
non-atmospheric pressure on the initial configurations for the pulling runs.
4.2.2 Analysis of simulation results
To facilitate the analysis of the results of the unfolding simulations, several segments in
the globular bottom are distinguished and indicated in Figure 4.2. The N-terminal helices
that belong to the coiled coil (residues 112 to 128), together with the short β-hairpin that
lies on top of them (residues 129 to 145), are coloured purple in the figure and are called
the ‘top’ part. The two alpha-helical motives in the rest of the chain are called helix G
(residues 146 to 154) and helix H (163 to 171). The protein structure representations in
the figures were done using VMD.23
In the postfusion conformation of HA2, the top part maintains its secondary and ter-
tiary structure with respect to the prefusion structure, while the rest of the chain has
unfolded and dissociated to form a leash along the central coiled coil. Therefore, the un-
folding of helices G and H (loss of secondary structure) and their dissociation from the rest
of the protein (loss of tertiary structure) are of primary interest. In all simulations, both
helix G and H have dissociated from the top at a pulling distance of 11.5 nm between the
N- and C-terminal of a chain. This distance corresponds to the length of an extended chain
of residues 146 to 175. The moment at which this pulling distance was reached is called
the macroscopic unfolding event, at which the simulation was stopped. For each run, we
established which chain reached the macroscopic unfolding event first (the ‘fastest chain’).
The statistical significance of the difference between average macroscopic unfolding times
was determined using a two-tailed heteroscedastic t-test, with significance levels *p < 0.1,
**p < 0.05 and *** p < 0.01.
Two specific measures of time are used in describing events one length scale lower
than macroscopic unfolding: the segment unfolding time and the segment dissociation
time. The pulling on a chain can cause unfolding of a helical segment in the chain, but
subsequent dissociation of that segment from another part of the protein might temporarily
reduce the load on that segment, possibly restoring helicity. This would generally happen
within 10 ns after the initial unfolding. Therefore, the unfolding time of a helix is defined
as the moment at which the helical content of the segment is zero and stays zero for at least
10 ns. The helical content of a segment is taken to be the number of consecutive residues
(at least three) in a helical conformation divided by the number of residues in the segment,
while a residue is regarded to be in a helical conformation if its backbone dihedral angles
φ and ψ are in the range [−100◦,−30◦] and [−67◦,−7◦], respectively.15 The segment
dissociation time is defined as the last moment at which the minimum distance between
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all heavy atoms in the segment and all heavy atoms of the top part is less than 3.5 Å. In
the calculation of the dissociation time of helix G, the top part is limited to residues 112
to 140 in order to exclude the nearest neighbours of helix G.
Hydrogen-bond analysis was employed to dissect the unfolding pathway on a residue-
level. Hydrogen bonds are defined between residues with a maximum distance of 3.5 Å
(a) 52 ns (b) 252 ns (c) 280 ns (d) 296 ns
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(e) Evolution of chain unfolding during a single pulling simulation.
Figure 4.3: Series of unfolding events (a-d) in the globular bottom of H3 during a typical, concurrent
unfolding pathway and corresponding pulling distance (e), including helix G and H dissociation and
the macroscopic unfolding event. In (a-d) the residues in helix H of the fastest chain are shown as red
sticks. The cartoon representation is used for the top (purple), the fastest chain (yellow), including helix
G (green), and the other chains (gray).
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between the donor and acceptor atoms, with a 30° maximum donor-hydrogen-acceptor
angle. In analogy to the segment dissociation time, a residue dissociation time, called ‘last
vertical contact time’, is defined to be the moment of the last hydrogen bond between
any residue in the range 146 to 175 and the top part. Hydrogen bond occupation was
calculated as the fraction of the time that the hydrogen bond existed until the last vertical
contact time.
4.3 Results
The steered molecular dynamics simulations give insight into the unfolding characteristics
of the globular bottom. Our analysis of the simulations starts with the unfolding pathway,
which is then used as a basis for a more in-depth study of the underlying critical interac-
tions. First, the results of the simulations on HA from the H3N2 viral strain are presented,
which will then be compared to those from the H1N1 strain.
4.3.1 Unfolding pathway of the globular bottom of H3
For the globular bottom of wild-type (WT) H3, 20 steered molecular dynamics simulations
were carried out, each with a different starting configuration of HA2112. The three chains
of the trimer unfolded concurrently in some simulations, while one or two of the chains
clearly unfolded much faster than the other(s) in other simulations. The analysis that is
presented next pertains to the fastest chain.
A typical, concurrent unfolding pathway is illustrated in Figure 4.3a to d, with a cor-
responding plot of the pulling distance during the simulations in Figure 4.3e. In the first
250 ns, the C-terminal of helix G (in red) is pulled away from the globular bottom (Fig-
ure 4.3a to b). While helix H is still having interactions with the top part, it unfolds (b),
after which the connection between helix H and the top is lost (c). Subsequently, rapid
dissociation of helix G and macroscopic unfolding ensue (d).
The correlation between the macroscopic unfolding event and loss of secondary struc-
ture in the individual segments G and H from all runs is shown in Figure 4.4a. It can be
seen that in all the simulations performed, helix H unfolds prior to macroscopic unfolding.
The unfolding of helix H is therefore highly correlated with macroscopic unfolding. The
mean regression coefficient of 0.82 indicates that on average, helix H has unfolded at 82%
of the macroscopic unfolding time. In contrast, helix G does not unfold before the macro-
scopic unfolding event and in most simulations not even thereafter, even though the load
is still being applied. This indicates a relatively high helical stability of helix G compared to
helix H, which can also be seen by the retention of secondary structure of helix G, unlike
helix H, in the postfusion conformation of HA.
The dissociation of both helix G and H (loss of tertiary structure) is highly correlated
with the macroscopic unfolding event. Moreover, regression coefficients of 1.0 and 0.9 for
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(a) Loss of secondary structure.
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(b) Loss of tertiary structure.
Figure 4.4: Correlation of the macroscopic unfolding time with a) unfolding times and b) dissociation
times of segments helix G (green) and H (red) in the fastest chain. The dots are data points from indi-
vidual simulations. The solid, coloured lines are fits from a linear regression model, with the regression
coefficient indicated. The black line indicates a slope of 1. Helix G did not unfold in some simulations, for
which some green dots and the fit are missing in the figure. The solid lines are regression curves through
the data corresponding to their colour, with the regression coefficients (slopes) indicated.
helix G and H respectively (Figure 4.4b) indicate a short delay between the dissociation of
the helix and macroscopic unfolding. As soon as helix H has dissociated, macroscopic un-
folding ensues rapidly and consistently. Because of this strong correlation and concurrence
of helix H dissociation with the macroscopic unfolding event, we conclude that dissocia-
tion of helix H is the critical event in the unfolding of the globular bottom of HA2. We
continue by unraveling the interactions between amino acids that are responsible for this
critical event.
4.3.2 Identification of critical interactions
A residue-level analysis was performed to investigate which of the residues have interac-
tions that are critical for chain stability. Since vertical contacts deliver most of the stability
against the vertical pulling, we determined the ‘last vertical contact time’ in all simulations
and studied the correlation to the time of macroscopic chain unfolding. As the chain under
consideration (the fastest unfolding chain) starts to unfold from the C-terminal, residues
will dissociate starting from the highest residue number (175 to smaller residue numbers).
When a residue is reached that makes a vertical contact with the top, chain unfolding and
dissociation will stop until the interaction is lost. A critical contact is defined as a vertical
contact that significantly delays further chain unfolding and that does this consistently in
(almost) all instances. Furthermore, after the critical contact has been broken, the chain
should unfold without further significant delay. Hence, the amino acid closest to the C-
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terminus that makes a vertical contact that consistently remains until macroscopic chain
unfolding can be considered critical. The absence of further delays in chain unfolding
should be reflected in a high correlation with macroscopic unfolding for that contact and a
high regression coefficient, here required to be at least 0.9. Additionally, the contact should
show consistency over all simulations by a low spread of the data around the regression
curve. Also, to be able to provide stability at all times, critical interactions should occur
throughout the simulation, so a high occupancy of vertical hydrogen bonds should be ex-
pected. Finally, it can be anticipated that the critical contact is made from within helix H,
based on the previously established critical role of this segment. However, in order not to
rule out important effects from residues that do not belong to helix G or H, all residues in
the globular bottom were included in the current analysis.
The regression coefficient with macroscopic unfolding for the last vertical contact time
per residue, and the occupancy of vertical contacts per residue are shown in Figure 4.5a
and c, respectively. Starting from residue 175 on the right in Figure 4.5a, Arg170 and
Arg163 have strikingly high occupancies, with on average more than two vertical hydro-
gen bonds per residue (Figure 4.5c). The occupancy of these residues is lower when they
belong to the fastest unfolding chain, indicating that they play a significant role in stabi-
lizing the chain. From Figure 4.5a, it can be seen that the residues Arg170 and Asn169
are the first residues that lose their vertical contacts, with regression coefficients of 0.25
and 0.54 respectively. This means that, although the occupancy of vertical hydrogen bonds
made by Arg170 is high, its vertical contacts are broken relatively early in the unfolding
process, as seen in Figure 4.5d. The next two residues with nonzero regression coefficients
are Ala166 and Glu165, but they both have a relatively low occupancy.
The first residue that meets the requirement of a regression coefficient above 0.9 and a
high occupancy is Arg163. The consistency of vertical contacts made by Arg163, the third
requirement, can be seen from the relatively small error in the regression coefficient for
this residue. By looking at the individual correlation data of Arg163 as shown in Figure
4.5b, it can indeed be seen that the data points have a low spread around the regression
curve (blue). Furthermore, this curve almost coincides with the regression curve of helix
H dissociation (red), highlighting the strong interconnection between the loss of vertical
contacts by Arg163 and the dissociation of helix H.
The next residue in the chain, Tyr162, also has a high regression coefficient, but the
data is more spread out (Figure 4.5d). Also, as the occupancy of vertical contacts made by
Tyr162 is very low, it can be inferred that the stability provided by Arg163 allows Tyr162
to make incidental vertical contacts until the contacts made by Arg163 are broken and
helix H dissociates. Altogether, its large regression coefficient, high occupancy and high
consistency of vertical contacts convincingly identify Arg163 to be the critical amino acid.
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(a) Relative chain unfolding delay per residue.
0 100 200 300 400 500 600 700 800










































(b) Residue-level dissociation time of Arg163.


















(c) Vertical contact consistency.






























(d) Residue-level dissociation time of selected residues.
Figure 4.5: Residue-level analysis of unfolding based on the last vertical hydrogen bond between a
residue in the unfolding chain and the top of the protein domain. a) Regression coefficients, obtained
from the correlation between the last vertical contacts in the fastest chain and macroscopic unfolding
time as shown, e.g., for Arg163 in b). c) Vertical hydrogen-bond occupancy per residue until the last
vertical contact time for the fastest chain and the ‘other chains’, averaged over 20 unfolding simulations
of WT H3. The error bars are smaller than the symbols. d) Individual correlation plots of the last vertical
contact time with the macroscopic unfolding time for residues Tyr162, Glu165, Ala166 and Arg170.
4.3.3 Salt-bridge network
Having identified the residue in the globular bottom that makes critical interactions with
the top, we are also interested in which residues in the top participate in these critical in-
teractions. As such, the hydrogen-bond occupancy between the residues in the bottom and
in the top is mapped in Figure 4.6. Together with Arg163, the residues Glu128, Glu131
and Arg170 all show a high occupancy in these contact maps. The residues Glu128 and
Glu131 are positioned at the C-terminal of the central coiled coil and in the β-strand that



























































































(b) Other chains contact map.
(c) Side view on the salt-bridge network. (d) Top view.
Figure 4.6: a) Hydrogen bond contact map of the vertical contacts made by the fastest unfolding chain
and b) the ‘other chains’. The colour indicates the occupancy of vertical contacts for that residue pair
until the last vertical contact time, averaged over all simulations of WT H3. c) Side and d) top view of
the prefusion crystal structure of WT H3, showing the salt-bridge network in the core of the globular
bottom. The segment colouring corresponds to that of Figure 4.1. Glu128, Glu131, Arg163 and Arg170
are drawn in licorice representation, labeled at their α-carbon atom and coloured as the corresponding
segment. The black dashed lines indicate the four most occupied vertical hydrogen bonds.
atively charged and are positioned in between the positively charged Arg163 and Arg170
in the prefusion crystal structure (see Figure 4.6a and b). The proximity and nature of
these oppositely charged residues, experiencing both electrostatic attraction and hydro-
gen bonding, allow them to form a network of stabilizing salt bridges in the core of the
globular bottom.
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In the fastest unfolding chain (Figure 4.6c), Arg163 prefers to interact with Glu128 but
also has contact with Glu131, while Arg170 predominantly has interactions with Glu128.
In the other chains (Figure 4.6d), both Arg163 and Arg170 have interactions with either
of the glutamates, while Arg163 prefers Glu131 and Arg170 prefers Glu128. The generic
sequence of events that can be deduced from this contact map and a close look at the
individual trajectories is as follows. In the fastest unfolding chain, Arg170 is being pulled
away from Glu131 rather early in the unfolding process, and will only make contact to
Glu128 until their moment of last contact at, on average, around 25% of the macroscopic
unfolding time (see Figure 4.5a and d). Meanwhile, in the same chain, Arg163 remains in
contact with its preferred partner Glu131, until this contact breaks. The remaining contact
of Arg163 with Glu128 lies beneath Glu131, and therefore causes a significant delay in
the macroscopic unfolding event. Thus, the dominant role of Arg163 in the stability of the





























































Figure 4.7: Average macroscopic unfolding times from constant force pulling simulations on the WT
(orange) and mutated (gray) globular bottom of H3 and H1 at neutral pH, and WT H3 in different
protonation states. The error bars indicate the standard error of the mean. The stars indicate the sig-
nificance level for the difference of the average with respect to the H3 WT (*** p < 0.01). A table with
significance levels between all given averages can be found in Appendix 4.D, Table 4.D.1.
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4.3.4 Mutation studies
To corroborate the influence of specific residues on the unfolding rate of the globular bot-
tom, a mutation study was performed. For each mutation, 10 to 20 simulations (depending
on the variance of the macroscopic unfolding time) were performed with settings and start-
ing configurations identical to the WT simulations (except for the mutation). The change
in stability due to the mutation is inferred via the average macroscopic unfolding time of
the mutant compared to the WT, as shown in Figure 4.7. The macroscopic unfolding time
of the WT was 269± 48 ns on average.
To confirm the decisiveness of vertical contacts made by Arg163, it was mutated to
an alanine residue (R163A). Alanine has a high helical propensity, so that the α-helical
structure of helix H is not disrupted by the mutation, but the ability of Arg163 to form salt
bridges is diminished. The average macroscopic unfolding time for the R163A mutant was
77± 12 ns (see Figure 4.7), significantly smaller than that of the WT and clearly validating
the designation of R163A as a critical residue. Mutation of Tyr162, a direct neighbour of
Arg163, resulted in an insignificant difference in the macroscopic unfolding time with re-
spect to the WT (see Figure 4.7), confirming the earlier suggestion that the high regression
coefficient for the last vertical contact times of Tyr162 arises just because of the stability
offered by Arg163.
Next, the salt bridging partners of Arg163 were mutated. Although Arg163 makes fre-
quent contacts with Glu128 in the WT (see Figure 4.6c and d), the E128Q mutation with
uncharged glutamine did not have a significant effect on the macroscopic unfolding time.
Detailed analysis of the results revealed that the long unfolding times of E128Q are caused
by the additional stabilization from a salt bridge formed between Asp160 and Arg127 that
was prohibited by the presence of Glu128 in the WT. The significance of the salt bridge
between Arg163 and Glu131 is once more confirmed by the E131Q mutation, resulting in
an almost identical average macroscopic unfolding time as the R163A mutant. The dou-
ble mutation E128Q-E131Q, in turn, results in significantly faster unfolding than only the
E131Q mutation, as it takes away all the opportunities of Arg163 and Arg170 to estab-
lish vertical contacts. The other two double mutants of H3, R163A-E128Q and R163A-
E131Q, show a slight increase in the average macroscopic unfolding time with respect to
the R163A mutant. However, the difference is not significant (see Table 4.D.1 in Appendix
4.D), while they still unfold much faster than the WT. This is to be expected because due
to the R163A mutation, neither Glu128 nor Glu131 is involved in a critical vertical contact
anymore.
4.3.5 Protonation studies
The simulations discussed so far, were performed at pH 7. However, as the pH of HA acti-
vation lies between pH 5 and 6, there are a number of residues that would get protonated
during the rearrangements. Therefore, the unfolding behaviour of the globular bottom
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at the pH of HA activation was investigated using static protonation of specific residues.
Histidine, with a model pKa of 6.5, would be the first to be protonated. So, initially, a
simulation with all histidine residues in our truncated model (HA2112) protonated was
performed (called His+). As shown in Figure 4.7, this did not lead to a significant change
in the unfolding time of the globular bottom, in line with the observation that none of the
histidines were involved in a critical vertical contact. However, the glutamic acid residues
Glu128 and Glu131, with a model pKa of 4.15, could undergo a structure-dependent pKa
shift and obtain a proton around pH 5. Upon protonation, the electrostatic interaction be-
tween the arginine and glutamic acid residues would become disrupted and each glutamic
acid would lose a hydrogen-bond acceptor. Indeed, protonation of Glu131 (E131+) leads
to an average unfolding time close to that of the E131Q mutant. Similarly, the combined
protonation of all histidines, Glu128 and Glu131 (His+E128+E131+) is in line with the
results of the E128Q-E131Q mutant.
4.3.6 Conservation of stabilizing amino acids
Having shown the effect of mutation or protonation within the salt-bridge network in H3,
conservation of these residues would implicate them in a generic, conserved molecular
Figure 4.8: ClustalW 29 multiple sequence alignment of residues 106 to 175 from HA2 of HA subtypes H1 to H18,
organized by phylogenetic group. The sequences were obtained from the online Influenza Virus Resource, 1 taken
from the strains listed in Table 4.D.2 in Appendix 4.D. The residues are coloured depending on their type at pH 5:
hydrophobic (gray), cysteine (pink), uncharged polar (green), positively charged (blue) and negatively charged (red).
Residues that are fully conserved over all subtypes are indicated with a ‘*’ on top, while mutations that maintain the
same biochemical properties are denoted with a ‘:’ (conservative mutation) or a ‘.’ (semi-conservative mutation).
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mechanism for the regulation of the stability of the globular bottom throughout HA sub-
types. To explore this, a sequence alignment for the globular bottom domain of all 18 HA
subtypes is shown in Figure 4.8. Apart from H1 (PR8) and H3 (X31), which were selected
because there is data on the fraction of non-productive HAs for these strains, the sequences
compared here were taken from arbitrary influenza virus strains, as listed in Table 4.D.2
in Appendix 4.D. HA subtypes are divided into two groups, based on their phylogenetic
classification. Group 1 is characterized by the histidine at position 111. This histidine is
located at position 106 in group 2, to which H3 belongs. It can be seen in Figure 4.8 that
within this group, Glu128, Glu131, Arg163 and Arg170 are fully conserved, except for one
conservative mutation (E128Q) in H10.
Unlike in group 2, the salt-bridge network is not conserved within group 1. The crit-
ical residue Arg163 is only present in two subtypes in group 1 (H17 and H18) and has
mutations to other polar residues otherwise. Although Arg170 is conserved as a basic
residue throughout both groups, the glutamates that act as hydrogen-bond partners for
the asparagines in the network are only scarcely found in group 1. There are mutations to
other polar residues at position 128, as well as hydrophobic and even positively charged
residues at position 131. Because most of the residues in the salt-bridge network are ab-
sent in group 1, the unfolding behaviour of the globular bottom from a subtype in group
1 might be different from that of H3 studied so far. This will be investigated in the next
section.
4.3.7 Stability of the globular bottom of H1
The stability of the globular bottom of H1 was studied using a setup identical to the pulling
simulations on H3. From the subtypes in group 1, H1 was selected because of the availabil-
ity of experimental data.36 Although the pulling characteristics of H1 could be different
from those of H3, which would require adjustment of the pulling force, the same pulling
force of 100 pN was used to enable a direct comparison of the results. As shown in Fig-
ure 4.7, the resulting average macroscopic unfolding time of WT H1 is 49± 7 ns, which
is significantly smaller than that of WT H3 and is more comparable to the E128Q-E131Q
mutant.
We next tried to stabilize the globular bottom of H1, informed by the results on H3. In
the sequence alignment in Figure 4.8, the critical arginine of H3 at position 163 is replaced
with a serine in H1, but applying an R163S mutation did not increase the average macro-
scopic unfolding time of H1 in our simulations (data not shown). This can be attributed
to a lack of salt bridging partners for Arg163 in the top of H1. With the triple mutation
S163R-N128E-K131E however, all residues participating in the salt-bridge network of H3
were present. This increased the average unfolding time of H1 by more than a factor 6,
to 314± 69 ns (Figure 4.7), which is not significantly different from that of WT H3, show-
ing that the salt-bridge network of H3 plays an important role in providing mechanical
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stability to the globular bottom.
4.3.8 Single-particle experiments
The predictions from the pulling simulations have been tested in single-particle fusion
kinetics experiments by colleagues in the Van Oijen lab at the University of Groningen,
The Netherlands, similar to the work by Otterstrom et al.36 The details of the assay, as de-
scribed by our colleagues, can be found in Appendix 4.A. In short, fluorescence microscopy
was used to track individual virus particles, that fuse with a supported lipid bilayer. La-
beled antibodies were used that bind to HA and inhibit its conformational changes, thus
mimicking the effect that a non-productive HA would have. The amount of antibodies per
viral particle was estimated from their fluorescence intensity. The yield of fusion, defined
as the fraction of the total number of particles for which hemifusion was detected, was
determined for different numbers of these inhibitors per virus particle.
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Figure 4.9: Stoichiometry of fusion inhibition and antibody binding from single-particle experiments
as supplied by the Van Oijen lab. 6 Data is shown for WT H3 (black circles) and the mutants E131Q
(green upwards triangles), R163A (orange squares), E131Q-R163A (red downwards triangles) and
E128Q-E131Q (blue diamonds). The coloured dashed lines are drawn as a guide to the eye through
the correspondingly coloured data points for each mutant, inspired by the shape of the curves from the
stochastic model of Ivanovic et al. 25
The results of the experiments are shown in Figure 4.9. Indicative curves (dashed) are
drawn as a guide to the eye through each of the data sets, as a schematic representation
of the stochastic model of Ivanovic et al.25 The results on WT H3 are in agreement with
those reported by Otterstrom et al.36 In the first of three regimes that can be identified,
the fusion yield remains constant at about 0.8 (below 500 inhibitors per particle) because
there are still enough HAs left to mediate fusion, despite the inhibition of a number of
them by the antibodies. In the second regime (between 500 and 1500 inhibitors), not all
of the particles have enough productive HAs left to mediate fusion and the fusion yield
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starts to decrease. For WT H3, the half-maximum fusion yield that can be used to quantify
the location of this transition regime lies at about 600 inhibitors per particle, as estimated
from the indicative dashed line. In the third regime (above 1500 inhibitors), the fusion
yield goes to zero because all available HAs have been inhibited.
The stoichiometry of fusion inhibition was also determined for a number of the H3
mutants described in Section 4.3.4. The mutations that destabilize the globular bottom
relative to the WT in the simulations are hypothesized to have a higher fraction of non-
productive HAs on the virus particle. As can be seen in Figure 4.9, the estimated half-
maximum fusion yield is decreased from 600 to 400 inhibitors by the E131Q mutation.
This indicates that the E131Q mutant virus has a higher fraction of non-productive HAs
than the WT, possibly because of the destabilization of the globular bottom induced by
knocking out the salt bridge between Glu131 and Arg163. The R163A mutation shifts the
half-maximum yield further to the left (to an estimated 300 inhibitors) compared to the
E131Q mutation. There is no quantitative difference between the average unfolding times
of the E131Q and R163A mutations in the simulations (Figure 4.7) that could explain
this difference in observations. However, the contact maps that were discussed in Section
4.3.3 point towards an added destabilizing effect of the R163A mutation, by knocking out
the vertical hydrogen bonds between Arg163 and both Glu128 and Glu131 at once. The
double mutation E131Q-R163A decreases the half-maximum fusion yield even further (to
about 200 inhibitors), presumably by leaving only the interaction between Glu128 and
Arg170 in the salt-bridge network. Finally, the fusion yield of the E128Q-E131Q mutation
is 0.15 at most. Based on our simulations, this result might be attributed to the fact that the
double mutation knocks out all salt bridging partners in the top and effectively destroys
the network.
4.4 Discussion
The commonly accepted productive pathway of HA-mediated membrane fusion (top row
in Figure 4.1) is based on the assumption that the rate of B-loop extension is higher than
the rate of collapse in the C-terminal part of HA2. Recently however, it was found that
a major fraction of HA refolds non-productively during the fusion process,25 for reasons
that are not clear at this stage. Here, we tested the hypothesis that destabilization of the
globular bottom of HA2 can reduce the productivity of HA by favouring the non-productive
refolding pathway (bottom row in Figure 4.1), as hinted at by Lin et al.30
Using steered molecular dynamics simulations to investigate stabilizing molecular in-
teractions in the globular bottom of HA, Arg163 was identified as a critical amino acid,
which is part of a network of salt bridges in the core of the globular bottom that con-
trols its stability. This salt-bridge network appears to coincide with some of the critical
interactions for globular bottom unfolding that were found in simulations of HA by Lin
et al.30 in the static prefusion crystal structure of H3. We here propose that Arg163 also
74 4. Critical interactions in the globular bottom of influenza hemagglutinin
belongs to this cluster because of its interactions with Glu128 and Glu131, as indicated by
our simulations. Ni et al.35 have identified a second cluster, Glu150, Arg153 and His26,
which lies on the HA2-HA2 interface between the globular bottom and the fusion peptide.
However, the fusion peptide is the first to dissociate after HA activation16 and does not
play any further role in the collapse of the globular bottom. For this reason, we did not
include His26 in our study. The third cluster reported by Ni et al.35 consists of Asp158,
His159 and Asp160 in the globular bottom and Arg127 and Asn129 in the top of H3. In-
teractions between these residues appeared clearly in the analysis of our simulations of H3
(Figures 4.5c and 4.6), albeit with less occupancy and with a less dominant role than the
residues in the first cluster. In our simulations of H1 however, the residues corresponding
to this third cluster do play a significant role. In particular, Tyr157, Asp158 and Tyr159
in the globular bottom of H1 form hydrogen bonds with Asn128 and Asn129, and have
hydrophobic pi-stacking interactions with Tyr141 and His142 (data not shown). Of these,
residues Asn129 and Tyr157 are fully conserved among HA subtypes (see Figure 4.8). Our
results further show that in absence of the salt-bridge network residues Glu128, Glu131
and Arg163, the globular bottom of H1 is significantly less stable than that of H3. We
hypothesize that this relative instability causes the higher fraction of non-productive HAs
observed for H1.25 Conversely, it might be possible to stabilize the globular bottom of H1
by reintroducing these residues, as in our simulations of the S163R-N128E-K131E mutant,
for which experimental verification is in progress.
Besides the influence of mutations on the pathway of conformational changes of HA
discussed so far, our results suggest that protonation of residues in the salt-bridge network
might act as an intermediate trigger for the collapse of the globular bottom. HA activation
has been shown to start with the release of the fusion peptide below pH 6,24 correspond-
ing to the acidity inside the maturing-to-late endosome.28 At this point, the stability of the
salt-bridge network in the globular bottom gives the fusion peptides time to insert into the
membrane, because the participating glutamates are not expected to be protonated yet
(based on their model pKa of 4.2). As the endosome matures, more HAs become activated
and insert into the membrane, while the pH drops further. Below a certain pH, Glu128
and Glu131 do become protonated and initiate the collapse of the globular bottom and
subsequent zippering. This could happen at a pH above 4.2, because the local electro-
static environment within the protein can greatly shift the pKa of a residue with respect
to its model pKa.17,48 The existence of such an intermediate trigger could explain the high
fraction of non-productive HAs in the experiments, in which the instantaneous drop to
pH 5 might trigger globular bottom collapse concurrently with fusion peptide release. In
contrast, the pH drop is more gradual in vivo, so HA would have more time to insert its
fusion peptides into the membrane before a further decrease in pH triggers globular bot-
tom collapse, resulting in a higher productive fraction. Comparing the fusion yield and the
fraction of non-productive HAs at different levels of pH could be used to investigate this
hypothesis further.
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There might be another role for protonation of selective residues, in causing symmetry-
breaking of the extended intermediate. Several authors have already commented on the
topological difficulties when the threefold-symmetric HA is rearranging from the extended
intermediate to the postfusion conformation, while being attached to both the viral and
the target membrane.2,18,30 The asymmetry that is thus needed can arise due to stochastic
events in the timescale of globular bottom unfolding, such as the unsynchronized switching
of molecular interactions within individual chains. As an example, the protonation of the
buried residues Glu128 and Glu131 can switch off a salt-bridge interaction and is a highly
structure-dependent, stochastic event. So, it is not likely that all of these residues will
be protonated in all the chains at once. Our simulations indicate that as soon as one of
these glutamic acids becomes protonated in a certain chain, the dissociation of this chain
would cause consolidation of the other chains. The already unfolded chain could then
proceed to the zippering, thereby facilitating the interruption of symmetry. This symmetry-
broken state would allow HA to position itself more parallel to the membranes, making
room for the membranes to approach each other. This hypothesized asymmetric unfolding
of the globular bottom could be explored with long-timescale equilibrium simulations or
further pulling simulations, with only selected residues within a single chain protonated
or mutated.
There are a number of assumptions, limitations and possible shortcomings within our
model that should be addressed. First of all, our current hypothesis assumes the existence
of an extended intermediate, for which there is still no direct evidence. However, an alter-
native pathway of HA rearrangements that does not include the formation of an extended
intermediate also relies on a low unfolding rate of the globular bottom, as proposed by
Lin et al.30 In this pathway, HA activation causes destabilization within the hinge region
(residues 107 to 112), around which the protein bends while the globular bottom remains
intact. The fusion peptides that have been released due to the destabilization can then dif-
fuse into the viral or the target membrane. With at least one of the fusion peptides in the
target membrane, unfolding of the globular bottom allows the combined action of coiled-
coil extension and the zippering mechanism to pull the membranes together. Hence, in this
alternative pathway, destabilizing the globular bottom would also decrease the window of
opportunity for one or more fusion peptides to insert into the target membrane and would
therefore decrease HA productivity.
In our simulations, artifacts might have been introduced by disregarding all of HA1
and part of HA2 in our simulations. However, at the moment that globular bottom stabil-
ity becomes relevant in the pathway of HA rearrangements, the fusion peptide has already
dissociated and there are only a few interactions between the outside of the globular bot-
tom and HA1. So, while the truncation into HA2112 was mainly done to make the simu-
lations computationally more feasible, we assume that all the relevant interactions within
the globular bottom itself were still included. Further, the pulling conditions that were ap-
plied could have biased the results. However, the direction of pulling parallel to the long
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axis of the central coiled coil is reminiscent of the vertical load that would be applied to
an extended and inserted intermediate by membrane undulations in the biological con-
text. Also, although the pulling force of 100 pN was much higher than it would be in the
biological context, it was carefully calibrated to still allow for stochasticity in intramolec-
ular interactions. Furthermore, as evident from our results, the stochastic interruption of
a number of critical contacts determines the unfolding rate. So, although the used pulling
direction and force would not necessarily lead to the same unfolding behaviour as in vivo,
we are confident that the simulations are qualitatively correct in identifying interactions
between residues that are critical for the stability of this domain of HA under the applied
loading. We assume that these residues will be important in other unfolding pathways as
well. We also note that, due to the temporal spread of the hydrogen bonds breaking, the
resulting macroscopic unfolding times showed a large variance. However, 20 simulations
were carried out for the relatively stable globular bottoms that showed a large variance
in macroscopic unfolding times and 10 for the less stable ones that displayed much lower
variance. This was sufficient to calculate the significance levels between the averages and
obtain statistically relevant results, with standard errors of the mean within about 20 % of
the average.
A further limitation of the currently presented simulation results is the focus on vertical
contacts. Although we did not include them in our results, horizontal contacts between the
chains within the globular bottom did play a role in unfolding. The collection of critical
contacts that have been reported by Lin et al.30 also contained such horizontal interactions.
However, due to the asynchronous unfolding of individual chains in our simulations, the
residues in one chain slide along the residues of the neighbouring chain during the pulling.
This results in inter-chain interactions between almost all possible residue pairs, creating
a smeared out contact map. Because we did not find any consistent, critical interactions
within this data, we have chosen to focus only on vertical contacts made by the fastest
unfolding chain. A more complete profile of inter-chain interactions would be possible by
enforcing concurrent unfolding of the three chains, as if they were all connected to the
same plane (such as a membrane).
In the preliminary experimental results, decreased fusion efficiency was observed for
the R163A mutation, as well as for other disrupting mutations within the salt-bridge net-
work. This is consistent with the hypothesis that the stability of the globular bottom influ-
ences the number of productively rearranging HA proteins on the virus particle. However,
there could be alternative explanations for the trends observed in the experiments. Firstly,
any of the mutations could have led to differences in HA folding, HA expression or the
integrity of the virus particle as a whole during their production. For example, increased
particle size or lower HA incorporation on the virus particle would effectively reduce the
number of productive HAs as well. So, the mutant viruses should be examined for these
effects in a future experiment. Secondly, the mutation in the globular bottom could have
increased or decreased the activation pH of HA, e.g., by destabilizing the fusion peptide. In
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fact, a study by Daniels et al.13 has shown an elevated pH of H3 activation by a double mu-
tation that includes Arg163. However, with such an increase in triggering pH, a reversed
trend would be expected in the experiments. After all, more HAs would be activated at
the same pH, effectively increasing the fraction of HAs participating in the fusion process.
Conversely, a decrease in activation pH would lead to the trend as observed in the experi-
ments indeed. Although there are no direct indications in the prefusion conformation that
would explain such a stabilization of the fusion peptide by one of the mutations, computer
simulations have already shown that globular bottom unfolding can induce fusion peptide
release.31 So, to definitively rule out any effect of the mutations on HA activation, the
activation pH of the mutants should be measured. Lastly, mutation of Arg163 could cause
the observed decrease in fusion efficiency by a destabilizing effect on the zippering mech-
anism. Because Arg163 is part of the loop that binds onto the coiled coil in the postfusion
structure, the R163A mutation could reduce the binding affinity of this loop and thereby
the energy that HA can provide in the fusion process. Hence, more HAs would be needed
to mediate fusion, leading to the observed trend. Measuring the thermodynamic stability
of the postfusion conformation of the R163A mutant, to compare with that of the WT,10
could give more information on the extent of this effect.
4.5 Conclusion
Our mechanical unfolding simulations of the globular bottom of HA suggest a pivotal sta-
bilizing role for four ionic residues: Glu128, Glu131, Arg170 and, in particular, the critical
residue Arg163. The salt-bridge network that these residues form is conserved through-
out phylogenetic group 2 of influenza A, but the participating residues are mostly absent
in group 1. The observed trends in preliminary single-particle fusion kinetics experiments
might be consistent with a model of HA-mediated fusion in which destabilizing the glob-
ular bottom causes an increased fraction of non-productively refolding HAs on the virus
surface. However, further experiments are necessary to rule out that other effects from the
mutations are causing the observed trends. Knowing the specific, conserved amino acids
that determine the productivity of HA can potentially aid in the development of therapeu-
tics, using a strategy that targets conserved residues that are critical for protein function.
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4.A Appendix: Single-particle assay
The experiments were performed to match the work by Otterstrom et al.36 as closely as
possible, and a more detailed explanation of the methods can be found there. A brief
overview follows. Materials were purchased from Sigma-Aldrich unless noted otherwise.†
Virus and R18 labeling
Influenza A strains A/Aichi/2/1968 (X31, H3N2) and A/Puerto Rico/8/1934 (PR8, H1N1)
and the specific HA mutants were produced in and received from the Ivanovic lab at Bran-
deis University, USA. For labeling of the viral membrane, an appropriate amount of virus
stock was diluted to 0.5 mg/mL in PBS-EDTA (PBS with 0.2 mM NaEDTA, henceforth re-
ferred to as PBS only) in a volume of 20 uL. 0.1µL of 0.2 mM R18 (Rhodamine C18 sodium
salt, ThermoFisher) in DMSO was added, and everything was carefully mixed by pipetting
up and down. After standing at room temperature for 1 h in darkness, the virus-R18 so-
lution was added to a PBS-pre-equilibrated G-25 column (ThermoFisher) and allowed to
enter the bed, 480µL of PBS was added and the eluate discarded. Then, virus fractions per
two drops were collected by eluting with 1 mL of PBS, and the fractions of most concen-
trated virus were combined to about 350µL total volume. The most concentrated fractions
were determined by imaging 3µL droplets on a bare coverslip, and comprised fractions 2-6
or 3-7.
Fabs
crF8020 Fab fragments, and the AlexaFluor488-labeled version crF8020-AF488, were the
same stocks as used in Otterstrom et al.,36 stored at −80 ◦C. Detailed methods and char-
acterization are described in that reference.
Coverslip and flow cell
Experiments were performed in a 5-channel PDMS-chip self-adhesing to a glass coverslip
as described before. Briefly, polydimethylsiloxane (PDMS, Slygard 184; Dow Corning) was
mixed with the curing agent in a 10:1 ratio, poured on a mold and allowed to harden
for two days at room temperature. PDMS chips were cleaned before use by sonication
with 0.5 % v/v Triton-X and 70 % ethanol for 10 min each. Cleaning involved an additional
step of sonication with 1 M NaHCO3 for re-use. Glass coverslips (#1.5; Marienfeld) were
cleaned by sonication in detergent, acetone, ethanol (each 30 min) and 1 M KOH solution
(10 min) successively, and subsequently rinsed with large amounts of water. Polyethylene
†This appendix was supplied by Jelle S. Blijleven from the Van Oijen Lab (Single Molecule Biophysics) at the
University of Groningen.
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tubing (Bioseb) provided the connection between buffer reservoirs, the flow cell and the
syringe pump (NE-1000; New Era Pump Systems Inc.). Flow channel dimensions in the
imaging region were 0.2 mm height × 0.5 mm width.
Proteoliposome preparation
Methods and incubation times were as described before. Liposomes were formed by ex-
trusion through 200 nm-pore membranes (Avanti Polar Lipids), and composed of a 0.75 :
0.25 : 2.5× 10−5 ratio of DOPC:cholesterol:biotin-DOPE (Avanti Polar Lipids). Liposomes
were solubilized with Triton-X and the receptor protein GYPA (Glycophorin predominantly
glycophorin A) was added in an approximate ratio of 1:27 000 GYPA:lipid, correcting for
GYPA content per the manufacturer’s specification sheet.
Microscope specifications
All experiments were performed on an inverted microscope, under near-total-internal-
reflection conditions so that an even irradiation of the sample was assured. 488 nm and
561 nm lasers (Coherent) excited the AlexaFluor488 dyes and R18 molecules, respectively.
Fluorescence was split and collected onto two halves of an EM-CCD camera (Hamatsu) to
enable co-localization of Fab and viral-membrane signals.
Fusion experiment
After rinsing with PBS, proteoliposomes were drawn into the channel and left for 45 min
for the liposomes to spontaneously form a bilayer. The channel was then washed with PBS.
Bilayer integrity was confirmed with fluorescence recovery after photobleaching (FRAP).
The virus was incubated at room temperature with or without Fabs for at least 45 min to as-
sure binding saturation. The following steps were then performed directly after eachother
and with roughly the same timings: all of the virus mixture was drawn in; fluorescein-
streptavidin at 0.27µg/mL was drawn in to bind to the sparse biotin-decorated lipids in
the bilayer and provide a readout of the local pH conditons; rinsing with PBS; lastly, pH 5.0
buffer (10 mM citric acid, 0.2 mM NaEDTA) was drawn in quickly to acidify the channel
and trigger the viruses to fuse. Acidification typically happened at 7 to 9 min after intro-
ducing the virus into the channel and was complete within seconds. Fusion movies were
taken with 200 ms frame exposure time for 4 min, and the first and last five seconds were
imaged with the 488 nm laser off to allow rapid virus particle localization and fusion yield
determination.
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Data extraction and analysis
Virus particles were detected in the R18 channel with the 488 laser off by using a discoidal
averaging filter, and coordinates translated to the Fab channel. The time of acidification
(‘pH drop’) was determined by fitting an error function to the fluorescein background
signal in the 488 channel. The illumination profile was corrected for by filtering out peaks
and fitting a Gaussian to the whole field of view. A 7× 7 pixel region of interest was used
to extract R18 and Fab signal intensities per virus particle, and background was globally
corrected. Hemifusion was detected from a dequenching or dissipating virus spot signal.
Fusion yield, the fraction of the virus population undergoing hemifusion, was determined
by counting the number of virus particles at the beginning and end of the movie without
488 illumination on, by using a threshold combined with manual inspection. Single Fab
intensity was determined by flowing a low concentration (∼ pM) of Fabs diluted into the
same pH 5.0 buffer into a clean flow channel, rinsing, and imaging the single spots under
the same conditions as in a fusion experiment. This intensity was then used to calculate
the number of Fabs bound per virus particle averaged over the first 20 frames after the pH
drop.
4.B Appendix: H1 homology modeling 85
4.B Appendix: H1 homology modeling
Because there is no complete structure of H1 HA (from influenza A/Puerto Rico/8/34
H1N1) available in the database, the SWISS-Model web server (http://swissmodel.expasy.
org/) was used to build the model of H1 using the H3 HA structure (from influenza
A/Aichi/68-X31 H3N2, PDB entry 1HGF) as a target. The model quality, shown in Figure
4.B.1a, overall is high, except for the unstructured regions of the fusion peptide (residues
10 to 23), the B-loop (residues 57 to 75), and at the C-terminal. Only this C-terminal re-
gion is part of HA2112 and unfavourable conformations in this region are expected to dis-
appear during equilibration. An overlay of the resulting (unequilibrated) homology model
with the (incomplete) structure of H1 is shown in Figure 4.B.1b.
















(a) Model quality. (b) Structure alignment.
Figure 4.B.1: Homology modeling of H1 using the SWISS-Model web server, 4 with H3 (PDB entry
1HGF) as the target structure. The quality of the model is estimated by the web server using a local
distance difference test (LDDT) as shown in a). In b), a cartoon of the homology model (red) is overlaid
with the crystal structure of H1 (green), which only contains residues 1 to 160 of HA2 (PDB Code 1RU7).
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4.C Appendix: Constant pulling rate simulations
Protein unfolding can proceed either stochastically or deterministically, depending on the
pulling rate.38 At low to moderate rates, protein domains have time to spontaneously
unfold under the applied load, while at high rates, these stochastic events become irrel-
evant and unfolding will be deterministic. Generally, the pulling force in MD simulations
is in the deterministic regime to unfold the system of interest within a reasonable amount
of computing time. In the present study, an ‘optimal’ pulling force was determined that
was low enough to unfold the globular bottom without unfolding the central coiled coil.
So there should be enough time for stochastic processes, such as re-establishing helical hy-
drogen bonds, to maintain the integrity of the coiled coil during the unfolding simulations.
Additionally, stochastic breaking of hydrogen bonds is needed to let the globular bottom
unfold. Exploratory pulling simulations using a model of HA that contains more of this
central coiled coil, HA290, were used to determine this optimal pulling force.
Figure 4.C.1a shows the helical fraction of the bottom part of the coiled coil (residues
106 to 128) at different pulling rates. At rates above 1 Å/ns, the helices of the coiled
coil unfold rapidly, while at a maximum pulling rate of 0.2 Å/ns, they remain more than
90% helical. The corresponding average pulling force of about 100 pN (Figure 4.C.1b) is
considered to be the optimal pulling force, and was used for the pulling simulations on
HA2112 as described in the main text.

















0.2 Å/ns 0.1 Å/ns
1 Å/ns
(a) Coiled coil helix unfolding.



















(b) Pulling force at 0.2 Å/ns.
Figure 4.C.1: a) Average helical fraction of the helices in the central coiled coil (residues 106 to 128)
of HA290 at pH 7, while pulling at constant rates of 5, 2, 1, 0.2 and 0.1 Å/ns. b) The pulling force per
chain (blue, red, green) and the average over all chains (black) for pulling rate 0.2 Å/ns, with an orange
line drawn at the approximate average pulling force of 100 pN. All lines in a) and b) represent a 3 ns
running average.
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Table 4.D.1: Statistical significance of the difference between the average macroscopic unfolding times
shown in Figure 4.7, as determined by a two-tailed heteroscedastic t-test.
H3 H1











WT 1.000 0.860 0.001 0.839 0.001 0.000 0.003 0.008 0.397 0.003 0.000 0.000
Y162A 0.860 1.000 0.099 0.759 0.096 0.056 0.144 0.188 0.742 0.127 0.052 0.060
R163A 0.001 0.099 1.000 0.001 0.927 0.029 0.216 0.188 0.002 0.722 0.021 0.053
E128Q 0.839 0.759 0.001 1.000 0.001 0.000 0.003 0.007 0.306 0.003 0.000 0.000
E131Q 0.001 0.096 0.927 0.001 1.000 0.073 0.229 0.186 0.002 0.692 0.053 0.116
E128Q-E131Q 0.000 0.056 0.029 0.000 0.073 1.000 0.002 0.018 0.000 0.170 0.705 0.664
R163A-E128Q 0.003 0.144 0.216 0.003 0.229 0.002 1.000 0.599 0.009 0.735 0.002 0.004
R163A-E131Q 0.008 0.188 0.188 0.007 0.186 0.018 0.599 1.000 0.032 0.503 0.014 0.025
His+ 0.397 0.742 0.002 0.306 0.002 0.000 0.009 0.032 1.000 0.013 0.000 0.000
E131+ 0.003 0.127 0.722 0.003 0.692 0.170 0.735 0.503 0.013 1.000 0.139 0.211
His+E128+E131+ 0.000 0.052 0.021 0.000 0.053 0.705 0.002 0.014 0.000 0.139 1.000 0.451
H1
WT 0.000 0.060 0.053 0.000 0.116 0.664 0.004 0.025 0.000 0.211 0.451 1.000
S163R-N128E-K131E 0.598 0.588 0.007 0.728 0.007 0.004 0.013 0.019 0.233 0.011 0.003 0.004
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Table 4.D.2: The virus strains used for the multiple sequence alignment in Figure 4.8.
Subtype Accession Code Strain
H1N1 ADA83041 A/Puerto Rico/8/1934 (PR8)
H2N2 BAG72216 A/Adachi/2/1957
H3N2 AIU46019 A/Aichi/2/1968 (X31)
H4N6 AGG81749 A/American black duck/New Brunswick/00464/2010
H5N2 ADU20361 A/American black duck/Illinois/08OS2688/2008
H6N8 AKF34349 A/American black duck/Maryland/07OS2482/2007
H7N1 AAG10656 A/African starling/England-Q/983/1979
H8N4 AEM75966 A/American black duck/Illinois/4119/2009
H9N2 BAN15811 A/African stonechat/Vietnam/8/2009
H10N6 AGG83172 A/American black duck/New Brunswick/00471/2010
H11N2 AHZ21120 A/Adelie penguin/Antarctica/178/2013
H12N6 AGG84126 A/American black duck/New Brunswick/00998/2010
H13N9 ADB46159 A/American white pelican/Minnesota/AI-07-1819/2007
H14N3 AHJ57334 A/blue-winged teal/Guatemala/CIP049H105-15/2011
H15N2 ABB90704 A/Australian shelduck/Western Australia/1756/1983
H16N3 AHM98288 A/California gull/California/1196P/2013
H17N10 AFC35438 A/little yellow-shouldered bat/Guatemala/060/2010
H18N11 AGX84934 A/flat-faced bat/Peru/033/2010
5
Computation of hemagglutinin free energy difference by
the confinement method
Abstract
Hemagglutinin (HA) mediates membrane fusion, a crucial step during influenza virus cell
entry. How many HAs are needed for this process is still subject to debate. To aid in this
discussion, the confinement free energy method was used to calculate the conformational
free energy difference between the extended intermediate and postfusion state of HA. Spe-
cial care was taken to comply with general guidelines for free energy calculations, thereby
obtaining convergence and demonstrating reliability of the results. The energy that one HA
trimer contributes to fusion was found to be 34.2± 3.4 kBT, similar to known contribu-
tions from other fusion proteins. Although computationally expensive, the technique used
is a promising tool for the further energetic characterization of fusion protein mechanisms.
Reprinted with permission from Boonstra S, Onck PR, van der Giessen E. Computation of hemagglutinin free
energy difference by the confinement method. J. Phys. Chem. B. In press. Copyright 2017 American Chemical
Society. DOI: 10.1021/acs.jpcb.7b09699
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5.1 Introduction
The glycoprotein hemagglutinin (HA) catalyzes membrane fusion during invasion of cells
by influenza virus particles.2 HA is a homotrimeric class I fusion protein consisting of
two subunits, a mostly globular binding domain (HA1) and a fusion-active domain (HA2)
that is anchored in the viral membrane at its C-terminal. HA1 is disulfide-bonded to HA2,
whose central alpha-helical coiled coil forms the core of the trimer. HA1 facilitates binding
to receptors on the target cell membrane and holds the protein in a metastable configu-
ration. After endocytosis, acidification of the endosome triggers dissociation of HA1 and
release of fusion peptides at the N-terminal of HA2.16,22 A large conformational change in
HA2 ensues, as is evident from comparison of the prefusion and postfusion conformations
of HA.6,63 In fact, a pathway of HA rearrangements has been deduced, which involves two
large conformational changes.25 First, a loop-to-helix transition extends the existing coiled
coil and projects the fusion peptides towards the target membrane. In this hypothesized
‘extended intermediate’ state, the fusion peptides can insert into the target membrane,
thereby establishing HA2 as a bridge between the viral and endosomal membrane. Subse-
quently, the globular C-terminal domain of HA2 collapses and zippers up along distinct hy-
drophobic patches on the extended coiled coil, so as to bring the two membranes together
for fusion.47 Single-particle fusion kinetics experiments have shown that HA triggering
is the rate-limiting step, followed by fast HA extension and fusion peptide insertion. The
resulting intermediate state of HA remains alive until a local cluster of sufficiently many
HAs can jointly provide enough energy to fuse the membranes.25,29 However, the amount
of energy that each HA can contribute to this process has not yet been determined.
The free energy available per HA is valuable information in the development of an-
tiviral therapeutics. It is directly related to the number of HAs needed to surmount the
appreciable membrane fusion energy barrier, estimated at 30 to 90 kBT .
1,32,35,50 Both the
number of HAs and the free energy per HA influence the kinetics of fusion, which has
to be tightly regulated to ensure release of the viral RNA close to the target cell nucleus,
while avoiding degradation by the host immune system.52 Therefore, these two quantities
influence virus infectivity, dictate the minimal receptor density on the target membrane
and define the number of HA-targeting antibodies that will be needed to neutralize a virus
particle.42,43
To our knowledge, HIV-1 gp41 and the SNARE complex are the only fusion catalysts for
which the energy contribution to membrane fusion is known: 71 kBT for gp41 and 65 kBT
for SNARE, both determined using optical tweezers.21,31 Depending on the virus strain,
HIV-1 entry requires one to seven gp41 trimers,5 while one to three SNARE complexes can
mediate synaptic vesicle fusion.48 For HA-mediated fusion, the required number of trimers
has been estimated to be between three and six.3,17,29 owever, an experimental determina-
tion of the energy that HA contributes is still lacking. Alternatively, computational methods
may be used to compute this energy, but they bring a number of challenges for systems
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as large as HA. Computational difficulties arise mainly because of the vast conformational
space that needs to be sampled and many local energy minima in which the system can
get stuck.24 For example, targeted molecular dynamics is able to give insight into the pre-
to postfusion pathway,37 but an accurate free-energy profile along this path would require
further sampling with more sophisticated (and laborious) methods.45 Some researchers
have computed the conformational free energy gain of the loop-to-helix transition that ex-
tends HA2, thereby reducing the size of the system to only tens of residues.14,27 However,
in view of the described pathway of HA rearrangements, it is the entire free energy that is
released during the transition from the extended intermediate to the postfusion state that
needs to be calculated. In order to do so, a method is needed that makes the computation
of conformational free energy differences for such a large system feasible.
There is no generally accepted method for computing the free energy difference be-
tween conformational states of a macromolecule, which is a particularly difficult task
when the two conformations differ significantly from each other.24 As the two states of
interest do not overlap, the path-dependent approach requires integration over overlap-
ping intermediate states along some reaction coordinate to calculate the change in free
energy during the transformation from one state into the other. However, even though
the intermediate states do not need to be physically realistic, the establishment of a suit-
able reaction coordinate and reaction path is challenging and some paths converge much
slower than others.15 Moreover, the system can still become trapped in an energy basin,
even within the presence of a biasing potential. Additional reaction coordinates that bias
the phase space perpendicular to the original reaction coordinate might be necessary, es-
pecially for larger systems, at the cost of even more complexity.60
Instead, we here apply the confinement free energy method, proposed a few years
ago by Karplus and co-workers,44 to determine the conformational free energy differ-
ence between the extended intermediate and the postfusion state of HA. This method
is path-independent and has been used to estimate the free energy difference between
two conformational states by approximating the internal motions of a protein as a super-
position of harmonic oscillators.9,44,49 By applying enhanced sampling techniques and a
number of optimization strategies, in compliance with general guidelines for free energy
calculations, the result of our calculation shows convergence and consistency between two
different analysis techniques. We find that a conformational free energy of 34.2± 3.4 kBT
is available from one HA trimer. This value is of the same order of magnitude as the known
energies available from other fusion proteins, and is consistent with a model in which three
neighbouring HAs are needed to mediate fusion.29
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5.2 Methods
5.2.1 Confinement free energy method
The confinement approach10,20,44,59 is a path-independent method that can be used to
estimate the conformational free energy difference ∆GAB between two states, A and B,
without the need of a transition path. Its central idea is illustrated in Figure 5.1. Macrostate
A is transformed into a set of noninteracting harmonic oscillators, a, for which the free
energy Ga can be evaluated analytically. The work done to perform this transformation is
the confinement free energy∆GAconf. So, going from a to A in Figure 5.1, the conformational
free energy of state A is evaluated as
GA = Ga −∆GAconf. (5.1)
A similar operation is performed for state B. Completing the cycle, the conformational free
energy difference between the states can be computed as
∆GAB = (GB − GA) (5.2)
= (Gb − Ga)− (∆GBconf −∆GAconf). (5.3)
Focusing on the confinement procedure to calculate ∆GAconf first, the transformation
A→ a is accomplished by a series of molecular dynamics simulations, in which the system
of interest is confined to state a. To this end, the Hamiltonian is extended with a harmonic
restraint, centered at the positions of a reference structure X A0 ∈ A. This restraint increases
step-wise with each new simulation, proportionally with the parameter λ = 0, . . . , 1, until
the system can be considered purely harmonic at λ = 1. This corresponds to the Hamilto-
nian44







‖x i − x i0‖2
!
, (5.4)
which includes the potential and kinetic energy terms E(X ) and K(P), depending on the
system configuration X and the particle momenta P, respectively. The particle masses mi
are input for the restraint over all N particles, while ‖·‖ denotes the Euclidean norm and is
evaluated after a mass-weighted best-fit of the instantaneous particle coordinates x i with
the reference coordinates x i0. This best-fit alignment improves the convergence of the pro-
cedure by precluding work done on restraining rigid body motions. The mass-weighting
ensures the transformation into a set of noninteracting harmonic oscillators for which the
free energy (Ga) is known analytically, thereby obviating the need for normal-mode analy-
sis to determine∆Gab in a previous version of the method.10 The total work performed by
the restraint over all values of λ (windows) is the confinement free energy ∆Gconf, which




Uconf dλ, with Uconf(X ) = 2Mpi














∆GAB = ( Gb – Ga ) – ( ∆GBconf
 – ∆GAconf )
Figure 5.1: Thermodynamic cycle illustrating the confinement free energy method. The free energy of
macrostate A is estimated from the free energy Ga of the set of harmonic oscillators a, oscillating around
the reference structure X A0 , and the work ∆G
A
conf needed to harmonically confine A to a as computed
by thermodynamic integration. The conformational free energy difference between states A and B is
then found by combining the confinement free energies ∆GBconf −∆GAconf with the analytically obtained
harmonic free energies Ga and Gb (Equation (5.2)). On the right, the reference structures are shown
in cartoon and licorice representation for the EI (orange, state a) and PF (purple, state b) states. The
overlaid cartoon representations on the left depict representative conformations from the simulation with
the lowest restraint strength for each of the states. Rendered with VMD. 28
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Here, M is the total mass of the system, 〈ρm(X , X0)〉 is the mass-weighted root-mean-
square deviation (RMSD) of the sampled configuration X with respect to the reference
structure X0, and the ensemble average denoted by 〈·〉 is obtained from a simulation using
the Hamiltonian Hλ(λ). Calculating 〈ρm〉 this way in post-processing, Uconf effectively gives
the average work done by the restraint term during the simulation. Equation (5.5) is valid





with NDOF the number of degrees of freedom in the system and β = 1/kB T . In this limit,
the system behaves as a set of noninteracting harmonic oscillators, of which virtually all
the energy is due to the restraints. Reaching that point, ∆GAconf can be interpreted as the
‘anharmonic’ part of the free energy of state A. By subtracting this from the ‘harmonic’ free
energy of state a and changing the variable of integration in Equation (5.5) to ζ = λν2,
the total conformational free energy of state A is computed as
GA = Ga −∆GAconf (5.7)









where h is Planck’s constant. E(X A0) is the potential energy of the reference structure for
state A, which is obtained by taking the ensemble average of the potential energy at the
highest restraint frequency. The conformational free energy of state B can be obtained
similarly, using X B0 as the reference structure. The second term on the right-hand side of
Equation (5.8) is the free energy of the set of noninteracting harmonic oscillators repre-
senting a state, which is identical for two confined states with the same number of degrees
of freedom. Hence, if one is only interested in the difference in free energy between two
states, this term vanishes and
∆GAB = (E(X B0 )− E(X A0))− (∆GBconf −∆GAconf) (5.9)
=∆Gab −∆∆GABconf. (5.10)
5.2.2 Thermodynamic integration and MBAR
The confinement free energy (Equation (5.5)) can be calculated either directly using ther-
modynamic integration (TI)61 or via the multistate Bennett acceptance ratio estimator
(MBAR).53 When using TI with numerical integration, the trapezoid rule with linear in-
terpolation is not suitable due to the strong nonlinearity of 〈ρm(X , X0)2〉 as a function
of ν .59 Instead, the integration is performed using linear interpolation in logarithmic
space as follows.10 With a function y(k) that has been evaluated at the discrete points
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{a = k0, k1, k2, . . . , kM = b}, the area under the curve of this function between the points i
and j = i+ 1 is ∫ k j
ki
y(k) =
log(k j/ki)(k j y j − ki yi)
log(k j y j)− log(ki yi) ≡ I j . (5.11)





I j . (5.12)
The statistical uncertainty of the confinement free energy method arises mainly from
the sampling error in obtaining 〈ρm〉. To compute the error in the conformational free en-
ergy difference G, the error in ρm is propagated through Equation (5.8). When numerical
integration is used, the error propagates through Equations (5.11) and (5.12), as detailed
in Appendix 5.A.
To keep the uncertainty in the estimated free energy low, consecutive values of λ for
neighbouring windows should be spaced sufficiently close.54 The resulting spatial overlap
between the conformations obtained at each window can be exploited by using MBAR,53
which calculates the free energy by minimizing the uncertainties in the free energy differ-
ences between all states simultaneously. The benefit with respect to TI is that samples from
multiple simulations are combined to compute the overall free energy difference, which
increases the accuracy of the calculation. To do so, MBAR needs the difference in poten-
tial energy ∆Up,n between all pairs of windows p and q. These can be obtained from the
windows that have been simulated (p = q) using Boltzmann reweighting. While only the
restraint term differs between the potential energies of two states,∆Up,q can be calculated
from ∆Uconf for the set of k = 0, . . . , K sampled configurations Xk at restraint frequency νp
according to62






When using MBAR, an estimate of the statistical uncertainty that propagates from taking
the integral of Ucon f into ∆Gconf is provided by MBAR itself. While TI is sensitive to the
average curvature of the observable between the windows, the uncertainty in the result
from MBAR depends on the overlap between the windows. Therefore, an added advantage
of using MBAR is that the consistency of the free energy calculation can be verified by
comparing the answers from two different analysis techniques (TI in logarithmic space
and MBAR). Consistent answers between the two methods ensures sufficient sampling in
each window, as well as sufficient overlap between the windows.
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5.2.3 Guidelines for free energy calculation
In an effort to bring more standardization in free energy calculations, a number of best
practices have been proposed as general guidelines for the analysis of free energy calcula-
tions:33
1. Use uncorrelated samples.
2. Compare results from different analysis techniques.
3. Ensure overlapping distributions between the sampling windows.
4. Confirm sufficient equilibration and sampling in each window.
Considering that the method used in the present article has been proposed only recently,
and to ensure that the results presented are as accurate as possible, we will follow these
guidelines in the analysis of our results and we will refer to them when relevant in the
remainder of this article.
5.2.4 Equilibration and decorrelation of time series
In the calculation of the confinement free energy and its uncertainty, 〈ρm〉 should be de-
rived from uncorrelated datasets (guideline 1), obtained from systems simulated at equilib-
rium (guideline 4). Hence, to acquire uncorrelated samples, the data was subsampled with
a spacing of at least two times the autocorrelation time for each window.13 Furthermore,
the simulations are started from a configuration that is not necessarily an equilibrium sam-
ple for the Hamiltonian corresponding to that window. From this configuration, it will take
time for the system to reach equilibrium, especially when the autocorrelation time is long.
Therefore, the data needs to be equilibrated before it is used in the free energy calcula-
tions. To do so, a method was used based on maximizing the number of uncorrelated sam-
ples that remains after discarding the equilibration period.12 The MBAR implementation
of these decorrelation and equilibration strategies was used. All free energy calculations
reported here were performed using equilibrated and decorrelated time series, using the
autocorrelation of the ρm time series.
5.2.5 Crystal structures and simulation setup
We carried out confinement simulations of the extended intermediate (EI) and the postfu-
sion (PF) state of influenza hemagglutinin from the A/Aichi/68-X31 H3N2 strain. A struc-
tural model of the extended intermediate was obtained by aligning the coiled coils of the
prefusion (PDB code 1HGF51) and postfusion (PDB code 1QU111) crystal structures using
an RMS fit of residues 97 to 101 in VMD.28 Using this short stretch within the trimeric
coiled coil resulted in a fit that enabled a seamless combination of the two structures. For
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both states, all residues belonging to HA1 were removed and only residues 33 to 175 of
the three monomers of HA2 were used, because only these residues are present in the
postfusion crystal structure. The amino acid sequence of the extended intermediate was
matched with that of the postfusion structure by a C137S mutation. Residues were proto-
nated if their pKa in the postfusion structure was above 5, as calculated by PROPKA41,55
using the PDB2PQR web server.18 Because the EI state occurs at the same pH as the post-
fusion state, it was protonated identically. To limit the computational burden of dynamic
protonation, the protonation state of a residue was kept fixed throughout the simulation.
The confinement simulations were performed with the NAMD program,18 using the
Amber ff14SB all-atom force field38 and generalized Born implicit solvent (GBIS).57,58
These parameters were chosen after a comparison of the stability of the protein (in terms
of RMSD values) and the simulation speed using different MD packages, force fields and
water models (see Appendix 5.B for details). A short-range interaction cut-off of 1.4 nm
was used without a switching function, with a pair list distance of 1.6 nm. Non-bonded and
electrostatic interactions were calculated every time step, while pair lists were updated
every 10 time steps.
The temperature was maintained at 300 K using Langevin dynamics, with fric-
tion coefficients of 1 ps−1, 5 ps−1, 20 ps−1 and 100 ps−1 in the ranges of ν =
0 to 0.3, 0.3 to 1.5,1.5 to 5 and ν > 5 ps−1, respectively. Doing so, the autocorrela-
tion time at each of the oscillator frequencies is optimized, as proposed by Villemot et
al.62 Following the recommendation of the same authors, the simulation time step was
taken to depend on the restraint strength in order to sufficiently sample even the highest
frequencies. As such, a time step ranging from 1 to 0.01 fs was used for ν > 1 ps−1, ensur-
ing that each harmonic oscillator period contained at least 80 time steps. Simulations ran
for a minimum of 2.5× 106 time steps, depending on the convergence of each individual
simulation, resulting in a minimum simulation length of 100 ps for the high-restraint
range. Configurations were saved for analysis every 1000 time steps, but at most every
picosecond.
Even with these specific measures to eliminate errors due to the size of the integra-
tion time step, the mass-weighted RMSD occasionally showed distinct, short peaks at high
restraint strengths. These occurred when one or more atoms would deviate so far from
their reference positions, presumably due to the random (Langevin) force, that a couple of
time steps were needed to relax them back to their equilibrium positions. Such systematic
errors have previously been shown to cancel out when calculating the conformational free
energy difference between two states of a smaller system,10 but led to a number of rare but
obvious shifts in the confinement free energy in our results. Therefore, data points within
a sampling window that deviated more than four standard deviations from the ensemble
average, thereby clearly identified as out-of-equilibrium outliers, were discarded before
subsampling the data.
A time step of 2 fs was used to speed up the simulations at low restraint strengths,
98 5. Hemagglutinin free energy difference by the confinement method
where the conformational space of the protein is still relatively large and autocorrelation
times are long. For these simulations, all bonds involving hydrogen atoms were constrained
using SHAKE.26 In an alanine-dipeptide test case, the reduction in degrees of freedom ac-
companying these constraints did not influence the confinement free energy difference
below ν = 6ps−1, as shown in Figure 5.C.1 in Appendix 5.C. Apparently, for these values
of ν , the influence of constraining the small oscillations of hydrogens is negligible com-
pared to the relatively large RMSD values, especially when only the free energy difference
between the two states is considered. Nevertheless, SHAKE was applied conservatively for
ν < 1ps−1 only.
Replica exchange molecular dynamics (REMD) was used for ν < 1.76ps−1. REMD has
been shown to decrease the autocorrelation time below ν ≈ 2ps−1, but has no effect on
the autocorrelation time at higher restraint strengths.62 Four replicas were used at the
temperatures 300.00 K, 308.11 K, 316.44 K and 325.00 K, with exchange attempts every
1 ps. This resulted in configuration exchanges between replicas every 5 ps on average.
5.2.6 Window spacing and overlap coefficient
The windows in TI calculations are usually equispaced in logarithmic space. However,
Villemot et al.62 have shown that an increasingly narrow spacing is necessary with in-
creasing harmonic oscillator frequency ν in order to limit the free energy spacing between
the windows. Doing so, enough overlap between the windows can be maintained. To get an
estimate of the free energy spacing, we initially used 21 frequencies, equally spaced in log-
arithmic space according to the formula νi = 2.045× 10−2×1.9ips−1, i = 0,1, 2, . . . , 20.44
Because the sampled conformations still appeared to be too constrained at the lowest re-
straint strength, this range was subsequently expanded by adding the lowest frequency
at ν = 0.001ps−1. To interpolate between these data points, the most progressive rela-
tionship between the free energy difference and oscillator frequency proposed by Villemot
et al. was used.62 This meant that the data points were added in such a way that the
maximal free energy difference between each of the neighbouring simulations i and j was
determined using62






with a = 5kcal/mol and b = 1.55 kcal/mol. In the low frequency range (ν < 2 ps−1),
MBAR was used to estimate the free energy difference between the data points that were
not yet sampled. In the mid-range frequencies (2 < ν < 163 ps−1), the number of added
data points was based on the free energy difference calculated by TI between the two exist-
ing ones, and were equispaced in logarithmic space. To minimize the number of data points
that were needed for sufficient overlap in the high-range frequencies (ν > 163 ps−1), data
points were added and calculated iteratively, mid-way in logarithmic space between the





















Figure 5.2: Minimum potential energy during energy minimization of the EI (orange) and PF (purple)
crystal structures. The final configurations, with a potential energy difference of −222.9 kcal/mol, were
used as reference structures for each respective state in the confinement simulations.
The overlap between the sampling windows was characterized using the overlap coef-
ficient, which can be determined from the overlap matrix.33 The overlap coefficient was
calculated for each row of the overlap matrix, by taking the minimum value of the sum of
the non-diagonal elements in the same row, either to the right or to the left of the diagonal.
5.3 Results
We present the results of the confinement simulations and compliance to each of the guide-
lines for free energy calculations, as discussed in Section 5.2.3. The first of these guidelines
is already met by subsampling the data. In this section, the preparation of the reference
structures is described first. Next, completion of the confinement to a set of noninteracting
harmonic oscillators will be checked. Subsequently, the confinement free energy is calcu-
lated using both the TI and MBAR analysis techniques (guideline 2). Then, to corroborate
these results, the use of a sufficient number of windows and corresponding overlap be-
tween them is shown (guideline 3). Following the fourth and final guideline, sufficient
equilibration and sampling in each window then demonstrates convergence of the results.
Finally, the conformational free energy difference between the EI and PF state is calculated
from these results.
5.3.1 Energy minimization
Reference structures for the confinement simulations were obtained by thorough energy
minimization of the structures for the EI and PF state. The minimum potential energy
during the energy minimization is shown in Figure 5.2. Although neither of the states
have converged to an absolute energy minimum, the energy difference remains more or
less constant between the two states. The potential energy difference ∆Gab between the
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configurations at the end of these 107 steps of energy minimization was −222.9 kcal/mol.
These final configurations were used as reference structures X A0 and X
B
0 for the confinement
free energy simulations of the extended intermediate and postfusion state, respectively.
5.3.2 Confinement to the harmonic regime
The results of the confinement simulations are shown in Figure 5.3a as the direct observ-
able 〈ρm〉 at all sampled values of ν . The conformational space of the EI state is larger
than that of the PF state, as seen from the difference in 〈ρm〉 at low restraint strengths.
The upper inset in Figure 5.3a shows the same data in linear space, from which the large
curvature in 〈ρm〉 with respect to ν becomes more apparent. The bottom inset in the same
figure shows the locally linear behaviour of the data in logarithmic space, warranting the
numerical integration scheme of Equations (5.11) and (5.12).
Completion of the confinement procedure, by reaching a set of noninteracting har-
monic oscillators in accordance with Equation (5.6), is shown in Figure 5.3b. The curve
for the EI state is similar to that of the PF state. At the maximum harmonic oscillator fre-
quency that was sampled (ν = 1121 ps−1), the equality in Equation (5.6) was reached to
within 99.9 %.



















(a) The restraints reduce conformational space.
























(b) The harmonic regime is reached.
Figure 5.3: Results of the confinement simulations of the EI (orange) and PF (purple) state of HA. The
expectation values from the mass-weighted RMSD distributions are shown in (a), with the standard
deviation of the distribution indicated by the error bars. The convergence threshold from the right-hand
side of Equation (5.6) is shown as the dashed line in (b), together with the left-hand side of that equation
for each of the states.
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5.3.3 Confinement free energies
The confinement free energies of individual states with respect to the harmonic oscilla-
tor frequency ν are shown in Figure 5.4a. The curves shown here are calculated using
MBAR, but are indistinguishable from those calculated by TI in this graphical represen-
tation. The difference between the two confinement free energies (∆∆Gconf, see Figure
5.4b) is relatively small compared to the absolute confinement free energies at the highest
restraint strength, emphasizing the importance of accurate sampling and integration for
both states. The confinement of the EI state takes more energy than that of the PF state
in the range 10−3 < ν < 40 ps−1, causing a drop in ∆∆Gconf until −206.2± 1.1 kcal/mol,
as calculated by MBAR. At higher restraint strengths, the more compactly folded PF state
takes more energy to confine, and the energy difference goes back up, until it converges
to −202.5± 2.0 kcal/mol at ν = 1120 ps−1. The confinement free energy difference cal-
culated using TI converges to −202.1± 0.4 kcal/mol, which is well within the uncertainty
given by MBAR. The uncertainty estimated by TI is almost an order of magnitude lower
than that calculated by MBAR, because TI does not take into account the amount of over-
lap between the windows in this estimate. Hence, the result is consistent between two
families of analysis techniques, thereby satisfying guideline 2.
Before calculating the conformational free energy difference between the states resul-
ting from these confinement free energies, the validity of the estimate with respect to the
remaining two guidelines for free energy calculations will be confirmed first. To start with,
the number of sampling windows and the overlap between them will be discussed.
















(a) Cumulative work done by the restraints.




























(b) The EI state requires more work to restrain.
Figure 5.4: Confinement free energies for the EI (orange) and PF (purple) state (a) and the difference
between them (b). The results in (b) were calculated by MBAR (black) and TI (green), with their uncer-
tainties indicated by the bands in gray and light-green, respectively. The inset in (b) zooms in on the tail
region of the graph in the main frame.
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10-3 < ν < 1121 ps -1
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PF
(a) Adding more windows does not change ∆Gconf (TI).



















(b) The overlap between the windows remains above
the threshold.
Figure 5.5: (a) The resulting confinement free energy using TI over the whole frequency range, with
errors σ∆Gconf indicated by the error bars. The gray shaded area represents the uncertainty of the end
result to help assess convergence. (b) The amount of overlap that each of the sampling windows has with
its neighbouring windows, as calculated by the overlap coefficient.
5.3.4 Convergence: overlapping distributions
Convergence of the results for∆Gconf in terms of a sufficient number of sampling windows
is shown in Figure 5.5a. For both the EI and PF state, the result calculated using TI does
not change anymore between using half or all of the windows (within the error bars of
the result calculated over all windows). This, however, does not yet guarantee sufficient
overlap between the distributions of neighbouring sampling windows, which is an essential
requirement for accurate free energy calculations (guideline 3 in Section 5.2.3). Such
overlap cannot only be accomplished by using enough intermediate states at different
values of ν , they should also have a judiciously chosen spacing.
The overlap coefficient quantifies the amount of overlap between the sampled distri-
butions. An overlap coefficient of 0.25 would mean that half of the sampled configura-
tions could also be found in one of the two neighbouring windows. Any value above 0.03
is considered sufficient, while smaller value would cause incorrect free energy estimates
and underestimation of the uncertainty by MBAR.33 So the optimum, balancing overlap
between and sampling within the windows, lies somewhere in between 0.03 and 0.25.
Figure 5.5b shows that there is more than sufficient overlap between the distributions
over the whole frequency range. In fact, the window spacing strategy described in Section
5.2.6 turns out to be rather conservative for a large part of the frequency range, especially
in the mid-range frequencies (2 ps−1 < ν < 163ps−1) with overlap coefficients above 0.4.
Such a non-optimal overlap requires more sampling windows than is necessary, but in turn
provides the advantage that per window, fewer decorrelated samples are required for an
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2 < ν < 163 ps-1
EI
PF
(b) Adding more windows between 2< ν < 163ps−1 does
not change ∆Gconf (MBAR).
Figure 5.6: (a) The total number of samples obtained at 300 K in each window (black) and the number
of samples that remain after equilibration (red) and subsequent decorrelation (blue). (b) Using MBAR
for an increasing number of windows over a selected frequency range, the deviation in∆Gconf and σ∆Gconf
is shown with respect to those calculated over all windows.
accurate free energy estimate. As can be seen in Figure 5.6a, about 2500 to 4000 sam-
ples per window are acquired in this frequency range. In contrast, for frequencies above
ν = 163ps−1, where a more progressive window spacing strategy is used, the overlap co-
efficient remains around 0.1 and about 10 000 samples per window were acquired. So, for
these high-range frequencies, a four-fold increase in sampling is needed to maintain the
same error contribution per window as in the mid-range frequencies.
In contrast to TI, MBAR is particularly sensitive to the window spacing and the re-
sulting overlap between the observed distributions. Without overlap, MBAR either gives
highly diverging results with huge uncertainties if calculating a small number of windows,
or, if the number of windows is too high, it does not converge at all. In our case, this
applied to both the low-range (ν < 2 ps−1) and high-range (ν > 163ps−1) frequencies
as soon as more than half of the sampled windows was left out of the calculation. The
occurrence of overlap coefficients around 0.25 in these frequency ranges (Figure 5.5b) is
already an indication for such behaviour. Nonetheless, the window spacing is sufficiently
small in the mid-range frequencies (2 ps−1 < ν < 163ps−1), such that MBAR calculations
converge with reasonable uncertainties while using only portions of the total number of
windows in this range. The difference in the resulting ∆Gconf between using all or a subset
of the windows is shown in Figure 5.6b. For both states, the calculated confinement free
energy changes at most 0.5 kcal/mol between using all, or just a tenth of the total number
of windows in this frequency range. This is a relatively small deviation compared to the ab-
solute confinement free energies (Figure 5.5a), which are five orders of magnitude higher.
However, the uncertainty in the result increases considerably with decreasing number of
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windows, to 1.5 kcal/mol of added uncertainty when using a tenth of the original num-
ber of windows. This highlights the importance of using a sufficient number of judiciously
spaced sampling windows for an accurate free energy estimate with low uncertainty.
An adjustment of the window spacing strategy might prevent the occurrence of exces-
sive overlap that we see here. We suggest to combine the two strategies suggested by Ville-
mot et al.,62 which are sequentially adding intermediate frequencies over the whole range
and determining the maximal frequency spacing using a pre-calibrated function. Recog-
nizing in their and our results that a considerably larger window spacing can be used for
frequencies above 2 ps−1, the idea is to sequentially add intermediate frequencies in three
small frequency ranges (‘calibration’ ranges) to determine the maximal frequency spacing
function below and above 2 ps−1 individually. First, we propose that the whole frequency
range is sampled using about 20 equidistant frequencies (ν1, . . . ,ν20) in logarithmic space.
By making sure that the highest frequency enters the harmonic regime, these simulations
already provide a good indication of the total range of the confinement free energy, given
that they are well equilibrated and converged. While the window spacing would generally
be too large for MBAR at this point, such convergence can be monitored using thermo-
dynamic integration. Then, simulations are added at frequencies in between the first two,
center two (around ν = 2ps−1) and last two windows, until there is sufficient overlap
between at least two of the windows in each of these three ‘calibration’ ranges. If the over-
lap coefficient is much higher than 0.03, slightly larger spacings could be tried for further
optimization. The maximal free energy difference between two subsequent windows can
then be found by fitting Equation (5.14) on the free energy differences obtained in the
three ‘calibration’ ranges [∆Gi, j(νlow), ∆Gi, j(νcenter) and ∆Gi, j(νhigh)].
5.3.5 Convergence: equilibration and sampling
Regardless of the number of sampling windows, insufficient equilibration within each of
the sampling windows can skew the ensemble averages considerably with respect to the
ensemble average in equilibrium. Additionally, the ensemble averages can be skewed if,
in equilibrium, not enough samples have been gathered. Both types of skewness will be
reflected in an inaccuracy in the free energy that is not taken into account by the esti-
mated uncertainty. Therefore, in line with guideline 4, proper equilibration and conver-
gence should always be confirmed. The conventional way of showing convergence is to
calculate the free energy based on incremental fractions of the available data in the for-
ward direction of each of the time series. For converged time series, the ensemble averages
should not change when samples are added, so the resulting plot should settle rapidly (be-
tween using 40 to 60 % of the available data) to within the uncertainty of the final value.
An effective measure to uncover possible non-equilibrated windows is to include the time-
reversed convergence plot, which should also converge rapidly.33 As shown in Figure 5.7a,
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(a) Extending sampling does not change ∆Gconf.
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(b) Extending sampling does not change ∆∆Gconf.
Figure 5.7: Overview of the confinement free energies and uncertainties for the EI and PF state calculated
by MBAR (a) and the differences between them (b), depending on the number of sampled data points.
In the analysis, increasing fractions of data are taken from the time series in both the forward (É) and
reverse (Ê) direction, as indicated. The gray shaded area represents the uncertainty of the end result to
help assess convergence.
the confinement free energy difference is well sampled and equilibrated, as evident from
the rapidly converging forward and reverse plots in Figure 5.7b. With this, adherence to
all of the guidelines for free energy calculation has been shown, so the final result will be
calculated next.
5.3.6 Conformational free energy difference
The conformational free energy difference between the extended intermediate and post-
fusion state can be calculated from the potential energy difference between the reference
structures and the confinement free energy difference at the highest restraint frequency.
Using Equation (5.10),
∆GAB =∆Gab −∆∆GABconf (5.15)
= (−222.9)− (−202.5± 2.0) (5.16)
=−20.4± 2.0 kcal/mol (5.17)
=−34.2± 3.4 kBT . (5.18)
This result shows that the transformation from the extended intermediate to the postfusion
state of hemagglutinin is an exergonic reaction that is thermodynamically favourable and
that can supply an estimated free energy of −34.2± 3.4 kBT per protein to the membrane
fusion process.
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5.4 Discussion
The extensive conformational changes in hemagglutinin serve to overcome the kinetic
barriers in membrane fusion. The amount of free energy that is available to accomplish
this task was unknown. Computation of this quantity is inherently challenging because
of the size of the system and the extent of the conformational changes. We tackled the
latter obstacle by using the confinement method, thereby avoiding the need to sample
all conformational space along the path of the structural changes and only focusing on
sampling the two end states. Before going into the implications of our findings in the
biological context, we first discuss our experiences with this approach in terms of efficiency
and possible sources of errors.
During the confinement free energy calculations, convergence was monitored to ensure
sufficient sampling, adhering to the guidelines for free energy calculations.33 Although
such careful assessment of convergence and propagation of the sampling error already
provides an estimate of the statistical uncertainty, the calculations also suffer from system-
atic errors. These arise from inaccuracies in the determination of the ensemble averages,
due to e.g., the integration over too large a time step, or an inaccurate force field. Others
have already investigated the systematic error due to the size of the integration time step,
which was shown to cancel out when taking the difference between the confinement free
energies of two states.10 In our results however, some rarely occurring, larger inaccura-
cies caused more obvious shifts in the confinement free energy that did not cancel out.
The RMSD at these data points clearly deviated from the ensemble distribution and were
discarded as outliers.
The errors introduced by inaccuracies in the parameters of the force field or water
model are more difficult to evaluate. For example, the confinement free energy method
has recently been extended for use with explicit water, in which the protein might behave
differently.19 However, the current study was feasible only by the efficient acceleration
of the implicit solvent model on GPUs, combined with the advantage of sampling with
a relatively low friction coefficient. Obtaining converged results in the relatively viscous
environment of explicit water currently seems to be out of reach. In a recent study however,
the combination of Generalized Born implicit solvent with the Amber ff14SB force field as
used here yielded accurate folding to the native conformation for 14 out of 17 proteins
with varying properties.40 Such a score indicates that the parameters used are accurate for
the determination of free energy minima and the corresponding protein conformations, as
in our calculations.
In addition to systematic errors, insufficient equilibration is a source of statistical un-
certainty that is also hard to quantify. Despite monitoring both the forward and back-
ward averages, there could always be unsampled events that reveal a longer correlation
time, requiring extension of the simulation time.23 Inclusion of additional restraints has
been proposed to bypass this problem, speeding up equilibration by lowering correlation
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times.10,62 This might however change the definition of the macrostate and thereby affect
the resulting free energy by an unknown amount. Related to this, the fact that the defini-
tion of the macrostate may be somewhat arbitrary is a problem for free energy calculations
in general.24 Moreover, we used a hypothesized model for the reference structure of the EI
state. We therefore chose not to introduce any additional constraints. Because the results
show that only the PF state is stable (has a constant RMSD) at low restraint strengths,
additional constraints are expected to decrease the confinement free energy of the EI state
(∆GAconf) the most, decreasing the difference between the two (∆∆G
AB
conf). This would in
turn enhance ∆GAB, which means that the current calculation is a lower bound for the
absolute conformational free energy difference between the two states.
In order to reach convergence and limit the uncertainty, we followed the recommenda-
tions to balance accuracy and efficiency in the confinement free energy method by Villemot
et al.62 However, simulation of 19.4× 109 time steps altogether (including all replicas)
still is a huge computational effort, despite acceleration of the simulations on graphical
processing units (GPUs)†, following recommendations in terms of window spacing, mon-
itoring correlation times and the use of REMD. Presumably, convergence to the same ac-
curacy could have been accomplished more efficiently by an improved window spacing
strategy that avoids excessive overlap. Especially in the low frequency range (ν < 2 ps−1),
where equilibration takes most of the simulation time and the use of REMD quadruples
the amount of required resources, the window spacing should be optimal from the start.
In order to improve the window spacing in future applications, we propose to find the
optimal intermediate frequencies by combining two approaches that have been suggested
by Villemot et al.62 By calibrating the desired free energy difference between windows
by sequentially adding intermediate frequencies (first approach) in three small frequency
‘calibration’ ranges (low, intermediate and high), the maximal free energy difference func-
tion (second approach) can be fitted between these calibration ranges. Doing so should
prevent the excessive overlap between windows in the intermediate frequency range that
was seen in our results. However, to verify this would require more simulations, so this
can better be done on a smaller system first. Although a number of simulations has to be
carried out consecutively in the proposed strategy, we expect that a more efficient spacing
of the subsequent parallel simulations will supersede this disadvantage.
There is a final subtle aspect in the confinement free energy method that is easily
overlooked. Because rigid-body motions have been removed by the best-fit alignment, the
translational (Gtrans) and rotational (Grot) degrees of freedom should be taken into account
separately. Of these, the translational components of the free energy are the same for both
states and cancel out. For a protein anchored in the membrane, the only rotational degree
of freedom (around the longest axis) is negligible and ∆GAB remains unchanged. When
†Computing one time step in 5 ms, 19.4× 109 time steps is equivalent to almost 27 000 h or 1125 d of com-
puting time on one nVidia Tesla K40m GPU and four Intel Xeon E5-2680 v4 (2.4 GHz) CPUs, or on 32 Intel Xeon
E5-2697A v4 (2.6 GHz) CPUs.
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a protein is free in solution, the rotational components are generally not the same for
both states. Although the EI state is significantly more extended than the PF state, we find
the difference ∆GABrot to be only 0.5 kcal/mol. This results in a conformational free energy
difference of ∆GAB =−33.4± 3.4 kBT for the protein free in solution.
The conformational free energy of the postfusion state of HA was found to be
34.2± 3.4 kBT lower than that of the extended intermediate. This amount can be
interpreted as the contribution of one membrane-embedded HA to membrane fusion in
the biological context of influenza viruses entering a cell. Although direct experimental
validation for this result is not yet available, circumstantial evidence suggests that it is
close to what one would expect. For example, it does not exceed the membrane binding
affinity of the three HA fusion peptides together (about 43 kBT ; three times the binding
free energy of the P20H7 fusion peptide reported by Li et al.36), for otherwise, the fusion
peptides would be pulled out of the target membrane upon HA collapse.25 Moreover, the
estimated energy is close to the energy from partial or full SNARE complex formation,
respectively 35 or 65 kBT , with one to three SNARE complexes mediating fusion.
48
Our result indicates that influenza fusion is catalyzed by one to three fusion proteins
as well, considering that the hydration barrier for hemifusion has been estimated at
30 to 90 kBT .
1,32,35,50 Combining this with the three to six HAs involved in fusion that
others have suggested,3,17,29 three neighbouring (X31) HAs currently seems the best
estimate.29,30 For further comparison, the free energy that is available from an extended
state of a single trimeric HIV gp41 fusion protein to the postfusion state is about 70 kBT .
31
Although much higher than our estimate for HA, it is consistent with a picture of fusion
mediation by only one gp41 for HIV,64 which takes considerably more time than for
influenza,39 presumably because of the remaining ∼20 kBT barrier.25
Application of the confinement method on the known or modeled conformations of
other fusion proteins, specifically gp417,8,46 and the SNARE complex,56 would enable a
direct comparison with free energies obtained in experiments. However, the prefusion state
of the SNARE complex constitutes a separate monomer and dimer, which are both mainly
disordered. This makes the definition of this state for the confinement free energy method
rather arbitrary and the result would therefore be unreliable. For the gp41 fusion protein,
a structural model of the extended intermediate was found to be highly dynamic in our
simulations, which would mean high RMSD values and unfeasibly long computation times.
Hence, a direct comparison with experiments can only proceed once these problems have
been alleviated.
As a possible step in the future, the trajectories of the current results could be analyzed
to find the per-residue contribution to the free energy difference.49 From this refinement,
the amino acids that contribute most could be compared with the documented effects of
certain mutations on hemifusion.4,47 Alternatively, the effects of certain mutations on the
conformational free energy of the postfusion state could further be investigated using a
new series of confinement simulations.9 It would also be interesting to investigate HA
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from an H1N1 strain, which we expect to release less energy because it shows a marked
difference in fusion efficiency with H3 HA.43 If so, comparing the per-residue contributions
between the two strains would give valuable information about the conservation of highly
contributing amino acids.
5.5 Conclusion
The confinement free energy method was used to calculate the energy that hemagglu-
tinin has available for membrane fusion. This energy is assumed to be equivalent to the
conformational free energy difference between a model of the extended intermediate and
the postfusion crystal structure. Convergence of the results was achieved by following
the specific recommendations for the confinement method given in the literature, and
at the same time complying to the general guidelines for free energy calculations. One
membrane-anchored HA trimer was found to contribute a free energy of 34.2± 3.4 kBT to
the membrane fusion process, consistent with current estimates of the number of HAs and
free energy barriers in membrane fusion, as well as with free energy contributions that
have been obtained for other fusion proteins. Although computationally expensive, the
used method has potential in the search for residues that contribute most of the energy
for fusion. Knowledge of specific conserved residues that are key to the fusion mechanism
may inspire the design of a physics-based drug that targets these residues.
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5.A Appendix: Error propagation
In general, for a quantity x = f (a, b, c) calculated from the uncorrelated observables a, b


















The derivation of this equation involves a first order Taylor expansion. It therefore only
holds as long as f is not very non-linear and the uncertainties are small compared to the
partial derivatives. Covariance terms must be added when the observables are correlated.
For the specific case of the confinement free energy, the ensemble average of ρm is the
only observable, with an uncertainty that is given by the standard error of the mean, σρ.
Individual values for 〈ρm〉 are taken from separate simulations, so they are uncorrelated.
The error in∆Gconf obtained by numerical integration can be estimated by propagating σρ
through the calculation of I j , defined in Equation (5.11), and the numerical calculation of
the integral in Equation (5.12), using Equation (5.19). This gives
σρ2 = 2〈ρm〉σρ, (5.20)
and
σI j =
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5.B Appendix: Force field and MD code selection
We tested the stability of both the EI and PF state of HA in different force fields and implicit
solvent water models. Default values of the cut-offs for non-bonded interactions belonging
to each of the force fields were used. The Langevin friction coefficient was 1 ps−1 and
the time step 2 fs with SHAKE26 on all bonds involving a hydrogen atom. Otherwise, the
parameters were the same as those described in the main text.
The results are summarized in Table 5.B.1, ordered by speed. Overall, it can be seen
that the longer simulations yield similar results for different force fields, with an RMSD
around 8 Å for the EI state and 4 to 5 Å for the PF state. The simulations were performed at
either pH 7 or pH 5, but, using the CHARMM36 force field with the EEF1-SB water model,
the results for the PF state show that the RMSDs can be compared regardless of the pH.
The combination of CHARMM36 with the GBMV implicit solvent water model was far
too slow. The combination of CHARMM27 with the FACTS water model gave the lowest
RMSD values for both states, but is still not very fast. CHARMM36 with the EEF1-SB water
model resulted in relatively high RMSDs with a moderate speed. The speed of CHARMM19
with EEF1 is comparable to that of GBIS with either Amber ff99SB-ildn or Amber ff14SB,
but the use of the latter results in lower RMSD values. Also, CHARMM19 does not scale
well beyond 16 CPUs using the CHARMM MD code, while GBIS runs very efficiently on
just four CPUs and a GPU, or on 32 CPUs, when using the NAMD package. Therefore, the
combination of the Amber ff14SB force field with Generalized Born implicit solvent was
selected for the confinement free energy simulations on HA.
Table 5.B.1: Force Field and Implicit Solvent Comparison for the EI and PF States at pH 5 and 7.a
FF Sol. MD Code State pH 〈ρm〉 Length (ns) Speed
(ns/day)
ff14SB GBIS NAMD EI 5 7.2 80 17
PF 5 3.8 74 17
ff99SB-ildn GBIS NAMD PF 5 8.0 66 17
C19 EEF1 CHARMM EI 7 8.6 148 16
PF 7 4.9 142 16
C36 EEF1-SB CHARMM PF 7 7.6 40 4
5 7.4 43 4
C27 FACTS CHARMM EI 7 4.5 19 2
PF 7 3.2 18 2
C36 GBMV CHARMM PF 7 5 2 <1
a The results for the EI state are marked gray. Length indicates total trajectory time; the indicated
speed corresponds to a 1 fs time step. Acronyms and abbreviations used: (FF) Force field; (Sol.) Im-
plicit solvent; (GBIS) Generalized Born implicit solvent; (C#) CHARMM#; (EEF1) Effective energy
function 1; (GBMV) Generalized Born using molecular volume.
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5.C Appendix: SHAKE test case
The effect of constraining hydrogen bonds with SHAKE in the confinement free en-
ergy method was assessed using the alanine dipeptide. This peptide is convenient for
parametrizations and validations due to its small size. It has also been used by Ovchin-
nikov et al. during the development of the confinement free energy method,44 which
enables us to validate our implementation of the method. We applied the confinement
free energy method as described in the main text to the alanine dipeptide, using the
united-atom CHARMM19 polar hydrogen force field in vacuum. The settings were similar
to those used by Ovchinnikov et al.,44 except that the NAMD package instead of the
CHARMM MD code was used. It is also worth mentioning that these settings include
infinite cutoffs for non-bonded interactions, because this has not been mentioned explicitly
in their paper. The two minima in the free energy landscape of the alanine dipeptide
were used as reference structures, corresponding to the backbone dihedral coordinates
(φ,ψ) = (60,−70) for state A (c7ax) and (−77,87) for state B (c7eq). The potential
energy difference between these reference structures is ∆Gab =−2.0 kcal/mol.















MBAR - no SHAKE
MBAR - SHAKE
TI - no SHAKE
TI - SHAKE
Figure 5.C.1: MBAR (black) and TI (green) results for the conformational free energy difference of the
alanine dipeptide in vacuum, using the CHARMM19 force field with (circles, dashed lines) and without
(squares, solid lines) SHAKE constraints on the hydrogen bonds.
The resulting confinement free energy difference between c7ax and c7eq is shown in
Figure 5.C.1. Without SHAKE, the result from TI (green squares) lies within the error of
the result from MBAR (black squares). This gives a conformational free energy difference
of −2.88± 0.15kcal/mol, which corresponds well with the −2.90± 0.05kcal/mol that
was reported by Ovchinnikov et al.44 With SHAKE (circles in lighter colours in the figure),
the confinement free energy difference starts to diverge from the result without SHAKE
from about ν = 6 ps−1 onwards. For higher restraint strengths, constraining the hydrogen
bonds removes a significant part of the vibrational freedom of the peptide. For values of
the restraint strength lower than ν = 6 ps−1, the effect of SHAKE on the confinement free
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energy difference is negligible, because the degrees of freedom offered by larger motions,
such as backbone dihedral and sidechain rotations, dominate the RMSD. Nevertheless,
in our calculations on HA, we chose the rather conservative value of ν = 1ps−1 as the
maximum restraint strength at which SHAKE was applied.
Summary
Every year, influenza, also known as the common flu, infects about a tenth of the world
population. Infection results in mild to severe disease symptoms and, for certain more
vulnerable people, can lead to death. Genetic mutations within the virus have allowed it
to evade the antiviral drugs that have been developed so far. By changing the biochemi-
cal appearance of the virus particles, these mutations generate new virus strains without
impairing their infectivity. In fact, a highly infectious influenza strain could emerge this
way at any time, potentially causing a pandemic. Only the development of a universal
anti-influenza drug, effective against all virus strains, could prevent all further infections
and eradicate the virus. Increased knowledge of the molecular details of influenza virus
replication could aid in the rational design of such a drug. This thesis focuses on the op-
erational mechanism of influenza hemagglutinin in mediating membrane fusion, a crucial
step in the influenza virus replication cycle.
Hemagglutinin (HA) is the most abundant protein on the outside of the virus and is
responsible for both target cell binding and membrane fusion during cell entry. It is there-
fore a natural target for the immune system, as well as for antiviral drugs. HA is anchored
in the membrane that envelops the virus and consists of a globular binding subunit, HA1,
which surrounds the fusion-active core, HA2. During infection, receptor binding domains
in HA1 attach the virus to host-specific receptors on the outside of the target cell. Sub-
sequently, the virus is internalized into the cell by endocytosis and transported within an
endosome towards the cell nucleus. Acidification of this intracellular compartment triggers
a series of conformational changes in the protein that ultimately lead to fusion of the viral
and endosomal membrane. This allows the viral genome to enter the target cell nucleus
to induce the production of new virus particles. These particles will be released to infect
other cells, completing the replication cycle.
Biological membranes, consisting of two lipid monolayers, have a hydrophilic surface
and a hydrophobic core. Fusing two of these membranes requires input of energy, because
it involves membrane stretching and bending, overcoming repulsive hydration forces be-
tween the lipid head groups and unfavorable aqueous exposure of hydrophobic lipid tails.
The HA fusion protein acts as a membrane fusion catalyst by providing this energy. Com-
parison of the molecular structures of HA at both neutral and low pH have led to a hy-
pothesized pathway of the conformational changes in HA2 that mediate membrane fusion.
After acidification, HA1 dissociates and an amphipathic fusion peptide at the N-terminus
of HA2 is released. Helix formation within a previously unstructured loop in HA2 projects
this fusion peptide over a distance of about 10 nm towards the target membrane, in which
it can insert. This extended intermediate connects the two membranes. The protein then
folds back on itself through a helix-to-loop transition and zippering of the globular bottom
of HA2, thereby pulling the membranes together for fusion. (Reviewed in Chapter 2)
A number of open questions regarding the molecular details of HA-mediated mem-
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brane fusion are treated in this thesis. In order to study the conformational changes of HA,
we used molecular dynamics (MD) simulations. In MD, the positions and velocities of in-
dividual atoms are calculated from the instantaneous interatomic forces over femtosecond
timesteps, based on a pre-defined force field. Because of differences in parametrization
conditions, some force fields are more suitable for specific systems than others. In the case
of the conformational changes of HA, we argue that the force field should produce the
right balance between loop-to-helix and helix-to-loop transitions because they play such a
central role. We show that the CHARMM36 force field can reproduce experimental helix-
coil transitions of small peptides at room temperature, given that the correct water model
is used. (Chapter 3)
Recent experimental findings indicate that multiple neighboring HAs are needed to
jointly overcome the energy barrier to membrane fusion. It also appears that more than
half of the available HAs is non-productive, presumably because the fusion peptides fail to
insert into the target membrane during the fusion process. However, the exact molecular
mechanism behind these non-productive events remain elusive. In this thesis, we explore
the stability of the globular bottom of HA2 against mechanical unfolding. We argue that
an untimely unfolding of the globular bottom can lead to non-productive refolding, be-
cause the extended intermediate would collapse before fusion peptide insertion. Using
steered molecular dynamics simulations, we find that the stability of the globular bottom
is governed by a network of salt bridges and we suggest a number of mutations that could
potentially decrease HA productivity. (Chapter 4)
Another persistent open question in the field is how many productive HAs are needed
for membrane fusion. This question is directly related to the amount of energy that a single
HA can supply to the fusion process. We calculated this amount as the conformational
free energy that is released during the transition from the extended intermediate to the
postfusion structure, using the confinement free energy method. This method avoids the
need to sample the enormous conformational space of this relatively large protein along
the whole transition. Instead, the start and end states are confined to a system of harmonic
oscillators, for which the free energy is known analytically. Although still computationally
demanding, we can show convergence of the results. The resulting 34.2± 3.4 kBT of free
energy that is available per HA is consistent with a model in which three neighboring HAs
are needed for membrane fusion. (Chapter 5)
Samenvatting
Ieder jaar wordt ongeveer een tiende deel van de wereldbevolking besmet door een influ-
enzavirus, beter bekend als de griep. Infectie leidt in het algemeen tot milde maar soms
zware symptomen die, vooral bij mensen die extra kwetsbaar zijn, kunnen leiden tot de
dood. Het virus heeft de antivirale medicijnen die tot nu toe zijn ontwikkeld steeds over-
leefd door genetische mutaties. Deze mutaties veranderen het biochemische uiterlijk van
het virus zonder de infectiviteit ervan te beïnvloeden, waardoor er nieuwe virusstammen
kunnen ontstaan. Er zou zelfs een zeer infectieve virusstam kunnen opduiken die een pan-
demie kan veroorzaken. Dit kan alleen voorkomen worden door een universeel vaccin
tegen het influenzavirus te ontwikkelen. Een dergelijk vaccin zou dus effectief moeten zijn
tegen alle mogelijke virusstammen, om op die manier het hele influenzavirus onschadelijk
te maken. Kennis van moleculaire details van de replicatiecyclus van het virus kan bijdra-
gen aan het rationeel ontwerp van zo’n vaccin. Dit proefschrift richt zich vooral op het
moleculaire werkingsmechanisme van influenza hemagglutinine voor het bewerkstelligen
van membraanfusie, hetgeen een cruciale stap is in deze replicatiecyclus.
Hemagglutinine (HA) is het meest voorkomende eiwit aan de buitenkant van het influ-
enzavirus en is verantwoordelijk voor het binden van het virus aan een te infecteren cel en
voor membraanfusie tijdens het binnendringen van de cel. Dit maakt het een logisch doel
voor het immuunsysteem en antivirale medicijnen. HA zit in het membraan dat om het
virus heen zit en bestaat uit een bolvormige kap (HA1), die zorgt voor het binden van het
virus aan de cel, en een fusie-actieve kern (HA2). Tijdens de infectie hechten receptorbin-
dende domeinen in HA1 het virus aan gastheer-specifieke receptoren aan de buitenkant
van de cel. Vervolgens wordt het virus in de cel opgenomen door middel van endocyto-
se en in een endosoom naar de celkern getransporteerd. Verzuring van dit intracellulaire
compartiment triggert een reeks conformatieveranderingen in het eiwit die uiteindelijk
leiden tot fusie van het virale en endosomale membraan. Hierdoor kan het virale genoom
de celkern binnentreden om de productie van nieuwe virusdeeltjes te induceren. Deze
nieuwe deeltjes worden daarna uitgestoten om andere cellen te infecteren, waarmee de
replicatiecyclus is voltooid.
Biologische membranen, bestaande uit twee lipide monolagen, hebben een hydrofiel
oppervlak en een hydrofobe kern. Het samensmelten van twee van deze membranen ver-
eist energie omdat het membraan hierbij moet uitrekken en buigen, er afstotende hydra-
tatiekrachten tussen de lipide kopgroepen ontstaan en vanwege de afstoting tussen hy-
drofobe lipide staarten en water gedurende het proces. HA werkt als een katalysator voor
membraanfusie door de benodigde energie te verschaffen. Het vergelijken van de mole-
culaire structuren van HA bij zowel neutrale als lage pH heeft geleid tot een algemeen
geaccepteerde hypothese over de aard en de volgorde van conformationele veranderingen
in HA die membraanfusie bewerkstelligen. Na verlaging van de pH dissocieert HA1 en laat
een amfipathische fusiepeptide aan de N-terminus van HA2 los. Deze fusiepeptide wordt
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door de transformatie van een ongestructureerd deel van HA2 naar een helische structuur
over een afstand van ongeveer 10 nm verplaatst richting het celmembraan, waaraan het
zich hecht. De zo ontstane ‘extended intermediate’ verbindt de twee membranen. Het ei-
wit vouwt zich vervolgens andersom weer op, waardoor de membranen bij elkaar worden
getrokken om te fuseren. (Gereviewd in Hoofdstuk 2)
In dit proefschrift wordt een aantal onbeantwoorde vragen over de moleculaire details
van door HA gemedieerde membraanfusie behandeld. Om de conformationele veranderin-
gen van HA te bestuderen hebben we moleculaire dynamica (MD) simulaties gebruikt. In
MD worden de posities en snelheden van individuele atomen berekend over een tijdspanne
van een femtoseconde, via de momentane interatomaire krachten op basis van een vooraf
gedefinieerd krachtveld. Vanwege verschillen in parametrisatie-omstandigheden zijn som-
mige krachtvelden geschikter voor specifieke systemen dan andere. Ons uitgangspunt is
dat, in het geval van de conformationele veranderingen van HA, het krachtveld de juis-
te balans tussen helische en ongestructureerde conformaties moet produceren, omdat de
transformaties hiertussen zo’n centrale rol spelen. We laten zien dat het CHARMM36-
krachtenveld voor kleine peptiden de bij kamertemperatuur gemeten conformationele ba-
lans kan reproduceren, mits het juiste watermodel wordt gebruikt. (Hoofdstuk 3)
Recente experimentele bevindingen wijzen erop dat er meerdere naburige HA’s nodig
zijn om gezamenlijk de energiebarrière naar membraanfusie te overwinnen. Het is ook
gebleken dat meer dan de helft van de beschikbare HA’s onproductief is, waarschijnlijk
omdat de fusiepeptiden tijdens het fusieproces zich niet aan het celmembraan hechten.
Het exacte moleculaire mechanisme dat deze onproductiviteit veroorzaakt is echter voor-
alsnog onbekend. In dit proefschrift onderzoeken we de stabiliteit van de onderkant van
HA2 tegen mechanisch ontvouwen. We betogen dat een voortijdig ontvouwen van de on-
derkant kan leiden tot onproductiviteit, omdat de ‘extended intermediate’ daardoor zou
terugvouwen voordat de fusiepeptides zich aan het doelmembraan hebben gehecht. Met
behulp van MD simulaties, waarbij een externe kracht wordt toegevoegd, stellen we vast
dat de stabiliteit van de onderkant wordt bepaald door een netwerk van zoutbruggen. Op
basis van deze constatering stellen we een aantal mutaties voor die de productiviteit van
HA zouden kunnen verminderen. (Hoofdstuk 4)
Een andere vraag die hardnekkig open blijft staan in het onderzoeksveld is hoeveel pro-
ductieve HA’s er nodig zijn voor membraanfusie. Deze vraag houdt rechtstreeks verband
met de hoeveelheid energie die één HA aan het fusieproces kan leveren. We beschouwen
deze hoeveelheid als de conformationele vrije energie die vrijkomt tijdens de overgang
van de ‘extended intermediate’ naar de postfusiestructuur en we hebben deze energie be-
rekend met behulp van de ‘confinement free energy’ methode. Deze methode vermijdt het
samplen van de enorme conformationele ruimte van dit relatief grote eiwit over de hele
transitie. In plaats daarvan worden alleen de begin- en eindtoestanden geleidelijk beperkt
tot het equivalent van een systeem van harmonische oscillatoren, waarvan de vrije energie
analytisch berekend kan worden. Ondanks dat deze methode nog steeds veel rekenkracht
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vereist, kunnen we aantonen dat de resultaten convergeren. De berekende 34.2± 3.4 kBT
aan vrije energie die per HA beschikbaar is, komt overeen met een model waarin drie
naburige HA’s nodig zijn voor membraanfusie. (Hoofdstuk 5)
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